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ABSTRACT 
 
 Lipids, including fats, waxes and sterols, are a group of naturally occurring 
cellular molecules that perform a diverse array of vital functions within every 
organism. Broadly, lipids directly or indirectly participate in signaling, act as 
building blocks within membranes, and function as highly efficient sources of 
energy.   In all these roles, lipids can heavily influence the chemical activities that 
sustain life—processes collectively known as metabolism. Lipids are composed 
of fatty acids and particularly, the lipids that constitute biological membranes are 
composed of long chain fatty acids. Long chain fatty acids, in order to be used for 
energy generation, membrane biogenesis, or signaling within the cell, need to be 
activated by esterification to Coenzyme-A. Long chain Acyl CoA Synthase 
enzymes catalyze this important esterification reaction and hence act as key 
metabolic regulators of fatty acid metabolism within the cell. The membrane fatty 
acid composition of a cell determines the protein composition of biological 
membranes and can thus define the developmental fate of a cell as well as its 
membrane bending and migratory abilities. In this regard, Acyl CoA Synthases 
can also act as key developmental regulators.  
 In the current study, we present evidence for the role of Long chain Acyl 
CoA Synthases (ACSL): Bgm and Dbb in Drosophila embryogenesis. 
Particularly, maternally deposited bgm transcript is required for the processes of 
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cellularization and neurogenesis during Drosophila embryonic development. 
Rab-5 tagged endocytic vesicles are critical sources of membrane components 
during cellularization, and Bgm is required for the proper subcellular targeting of 
these vesicles. Neurogenesis also requires maternal expression of bgm, and 
abnormal neurogenesis in bgm mutants appears to be related to the early defect 
in cellularization. In addition, we also demonstrate that bgm and dbb are 
duplicated genes with partially diverged developmental expression patterns and 
are transcriptionally regulated by dorsoventral patterning genes. Lastly, we 
provide evidence for behavioral abnormalities in bgm  and  dbb  mutant flies, thus 
making them attractive models of neurodegenerative disorders, which can be 
potentially used in large scale screens for diet and drug therapies. 
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 Lipids, including fats, waxes, and sterols, are a group of naturally 
occurring cellular molecules that perform a diverse array of vital functions within 
every organism. Broadly, lipids directly or indirectly participate in signaling, act as 
building blocks within membranes, and function as highly efficient sources of 
energy.   In all these roles, lipids can influence the chemical activities that sustain 
life—processes collectively known as metabolism.  
 Within a cell, lipids can themselves act as signaling molecules or facilitate 
protein signaling. The signaling pathways requiring lipids binding as ligands to 
protein receptors comprise the lipid signaling pathways.  Several different types 
of lipids can act as ligands.  As examples, ceramides are signaling molecules 
required for regulation of insulin signaling, senescence, and cell death (Chasan 
et al., 1992). Ceramides are composed of a sphingosine (2-amino-4-octadecene-
1,3-diol) head group and a fatty acid (a carboxylic acid with a long aliphatic tail); 
they bind to the ceramide receptor (Castro et al., 2014). Another lipid ligand 
derived from Sphingosine, Sphingosine-1-phosphate, is required for cell survival, 
cell migration, and inflammation (Mendelson et al., 2014). The Phosphotidyl 
inositol family of lipid second messengers includes inositol triphosphate (IP3) and
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Diacylglycerol (DAG). These two ligands are required mainly for calcium 
signaling in muscles and for activation of Protein Kinase C (PKC) (Schink et al., 
2013; Shisheva, 2013; Takasuga and Sasaki, 2013). Notably, all of these ligands 
are derived from lipids found in biological membranes (Goñi and Alonso, 1999). 
Several other lipid ligands, which are beyond the scope of discussion in this 
review, may or may not be derived from membrane lipids.  Additionally, lipids can 
also influence signaling in an indirect manner. Several protein ligands are 
activated by the addition of acyl chains derived from fatty acids. As an example, 
the conserved developmental regulator Sonic hedgehog is activated by 
palmitoylation (Buglino and Resh, 2012; Ho and Scott, 2002). Most, although not 
all, Wnt ligands are also palmitoylated for their conserved and essential functions 
in development (Bartscherer and Boutros, 2008).  
 The second essential role of lipids in an animals’ life history is as an 
essential source of energy. Most lipids are metabolized in either peroxisomes or 
mitochondria by the process of β−oxidation. When broken down, lipid constituent 
fatty acids generate significantly more energy than do carbohydrates or proteins 
(approximately 2.5 times more). The body also uses lipids to efficiently store 
unused energy in the form of lipid droplets. 
 The third essential role for lipids in all living organisms is as components 
of biological membranes—both cellular and subcellular.  Indeed, the lipid 
composition of the membrane defines the protein components imparting unique 
protein signatures and unique properties to each type of membrane (Bogdanov 
et al., 2014; Poveda et al., 2014; Schmidt and Robinson, 2014). At the plasma 
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membrane, lipids form a selective barrier, which maintains a stable environment 
within the cell while also maintaining a pathway for communication with the 
external environment. As examples, plasma membrane receptors determine the 
signaling pathways that are active within a cell, and anionic transporters 
determine which energy sources will enter the cell (Bogdanov et al., 2014; 
Record et al., 2014). Lipids can also affect membrane bending properties 
(Stachowiak et al., 2013). At the cellular level, different membrane lipid 
compositions can affect changes in cell shape, allowing cells to adapt to the 
demands of developmental or homeostatic processes like morphogenesis, 
migration, and inflammation, to name a few (Bogdanov et al., 2014; Mendelson 
et al., 2014). At the subcellular level, certain lipids are essential for vesicle 
biogenesis, while others assist in trafficking between subcellular organelles 
(Martin, 2001; Osborne et al., 2001; Wurtzel et al., 2012). Thus, the lipid 
composition of membranes dictates a cell’s energy state, developmental fate, 
and its ability to move and change shape in response to developmental or 
homeostatic demands. In this regard, some have suggested that the membrane 
roles of lipids cannot be overlooked in studies of any of their functions. 
 
Membrane Lipids and Fatty Acids 
 Lipids are amphiphilic in nature, having both a hydrophilic end and a 
hydrophobic end. In forming a bilayer, with their polar ends pointing outwards 
and the nonpolar ends pointing inwards, membrane lipids assemble to form the 
plasma membrane that separates the interior of the cell from the exterior 
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environment. The hydrophobic (nonpolar) part of the lipid consists of long 
hydrocarbon chains that are derived from fatty acids (a carboxylic acid with a 
long aliphatic tail). There are four major classes of membrane lipids: 
phospholipids, sphingolipids, glycolipids, and cholesterol, defined on the basis of 
their polar head groups. Phospholipids are the predominant type in membranes; 
they are formed in a multistep reaction whereby dihydroxyacetone phosphate, a 
central metabolite in glycolysis, is reduced to sn-glycerol 3-phosphate using 
NADH (Pol et al., 2014). In the next step, long chain fatty acids are transferred 
from acyl-ACP to sn-glycerol 3-phosphate to form phosphatidic acid. Finally, 
depending on the lipid synthesized, a specific hydrophilic group is added to the 
phosphatidic acid (Pol et al., 2014). The hydrophobic chains of membrane lipids 
are derived from long or very long chain fatty acids.  
 These fatty acids have 14 or more carbons in their acyl chains and help 
membrane lipids span the membrane, either in pairs to form the lipid bilayer, or 
as singletons, spanning the membrane in its entirety to facilitate curving 
(Stachowiak et al., 2013). Importantly, the different fatty acids impart specific 
membrane bending or protein interaction properties to a membrane. Taken 
together, membrane lipids influence the developmental and physiological state of 
a cell, in large part due to their fatty acid composition.  
 Fatty acids (FAs) are classified based on carbon chain length as short, 
medium, long, or very long (Agostoni and Bruzzese, 1992).  Short chain FAs are 
thought to function primarily as signaling molecules within the cell, medium chain 
FAs function primarily as energy sources, and long and very long chain fatty 
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acids as membrane components; however, these functions are not exclusive to 
each of these categories. As membrane components, long and very long chain 
FAs (LCFAs and VLCFAs, respectively) heavily influence signaling and energy 
generation by defining the membrane’s protein composition as discussed earlier 
in this chapter. In order to be incorporated in to membrane lipids, LCFAs and 
VLCFAs need to  be activated by esterification to Coenzyme A, and this reaction 
is catalyzed by Acyl CoA Synthases (Figure 1.1).  
 
Acyl CoA Synthases: Fatty Acid Activators 
 In order to be used for any catabolic, anabolic, or regulatory function 
within the cell, FAs must first be esterified to Coenzyme A (CoA) (Watkins and 
Ellis, 2012). This esterification activates fatty acids and allows their participation 
in enzymatic reactions. The esterification reaction is catalyzed by enzymes 
belonging to the Acyl CoA Synthetase/Synthase family. Acyl CoA Synthases 
(ACS) catalyze a two-step reaction that is ATP dependent and leads to the 
release of two AMP equivalents. In the first half-reaction, the FA substrate is 
adenylated, releasing inorganic pyrophosphate (PPi) (Watkins and Ellis, 2012): 
Fatty acid + ATP→ Fatty acyl−AMP +  PPi 
The ubiquitous enzyme pyrophosphatase, which can be found in soluble, 
mitochondrial, peroxisomal, and other subcellular fractions, rapidly cleaves PPi, 
effectively preventing reversal of this reaction. In the second half reaction, CoA 
displaces AMP, forming a thioester bond to yield the activated FA (Young and  













Figure 1.1: Lipids containing long/very long chain fatty acids induce 
curvature  in membranes 
Green circles in the above figure represent polar head groups, and white 
lines represent hydrophobic fatty acids in membrane lipids. Assembly of fairly 
short chained fatty acid containing lipids leads to a straight, noncurved lipid 
bilayer. Introduction of long/very long chain fatty acids or lipids containing 
these leads to a successive increase in membrane curvature with the 
increase in number of such lipids. The yellow circles represent polar head 
groups and yellow lines represent long/very long chain fatty acids in 








Anderson, 1974). ACS family members are homologous in sequence and 
identified based on the presence of two highly conserved motifs.  Motif I is a 10 
amino acid sequence typically located 200–300 residues from the N- terminus; it 
is an AMP-binding site defined by the consensus [YF]TSGTTGxPK.  Mutations in 
this site decrease or abolish catalytic activity (Black and DiRusso, 2003). Motif II 
harbors the ACS catalytic domain.  This motif shares homology with the ANL 
superfamily (Acyl-CoA synthetases, Nonribosomal peptide synthetase, 
Luciferase) and contains 36–37 amino acids with four positions reserved for 
hydrophobic residues (TGDxxxxxxxGxxxhx[DG]RxxxxhxxxxGxxhxxx[EK]hE) 
(Stinnett et al., 2007). The conserved arginine at position 18 is always found 
approximately 260 residues downstream of Motif I. Results of site-directed 
mutagenesis experiments initially suggested that Motif II functions as a signature 
motif, determining the substrate specificity of the acyl-CoA synthetase family 
members, although this has been disputed. It is now understood that there are at 
least four residues outside of and distant from Motif II that are required for 
substrate specificity (Stinnett et al., 2007). Protein structural studies based on 
sequence and spectroscopy indicate the presence of a substrate binding “tunnel” 
that ensures FAs of only a certain chain length are activated by a specific ACS 
(Black et al., 1997; Soupene and Kuypers, 2008; Stinnett et al., 2007).   Motif II, 
along with the four extra residues, forms the tunnel.  There is limited flexibility in 
substrate activation as long chain ACSs can also sometimes activate very long 
chain FAs (Stinnett et al., 2007) (Figure 1.2). In mammals, 26 ACSs have been 









Figure 1.2:	  Acyl CoA Synthases are required for fatty acid functions 
Fatty acids are activated by Acyl CoA Synthases (ACSs)  in the presence of 
ATP. Activated fatty acids like palmitate and myristilate are used for protein 
acylation and thus facilitate signaling. Fatty acids are used for membrane lipid 
synthesis and thus facilitate membrane biogenesis. Lastly they act as efficient 
sources of energy and also regulate gene expression and enzyme activity.  
9 
 
carbons) (Mashek et al., 2007). These ACSs include members of the long-chain 
acyl-CoA synthase (ACSL) family and the very long chain acyl-CoA synthase 
(ACSVL) family (including members of the Bubblegum family [ACSBG]- the 
mammalian ACS homologous of the Drosophila long chain ACS Bgm). Finally, 
some ACSVLs are dual functioning, serving as fatty acid transporters (FATPs) in 
addition to their roles as acyl CoA synthases. Dual functioning ACSVLs are 
sometimes also designated as Solute Carrier Fatty Acid Transporters (SLCA) 
(Abumrad et al., 1998; Schaffer and Lodish, 1994).  
 Long and very long chain ACSs are partitioned in the cell. Both FATP1 
and ACSL6 reside in the plasma membrane, ACSL4 resides in peroxisomes and 
the endoplasmic reticulum, and ACSL5  resides in the inner mitochondrial 
membrane (Gassler et al., 2007; Watkins and Ellis, 2012). As demonstrated by 
ACSL4, ACSL proteins can be present in multiple subcellular locations within a 
single cell; moreover, a single ACSL may vary in its subcellular location in 
different cell types (Küch et al., 2014). As examples, ACSL1 resides in the 
plasma membrane and in GLUT4 vesicles in adipocytes, on the endoplasmic 
reticulum in hepatocytes, and on mitochondria in epithelial cells (Mashek et al., 
2007). ACSBG1 and ACSBG2 are found in the cytoplasm of COS-1 cells, 
mitochondria of neuronal cells, and microsomes of cells in the testis (Mashek et 
al., 2007).  Cell-specific differences in ACSL localization may arise from splicing 
or protein-protein interaction differences that are specific to each tissue type. The 
differential subcellular localization of each of the ACSL/ACSVL/ACSBG isoforms 
points to cell type specific roles for ACSs.  Consistent with this view is the 
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demonstration that mitochondrial-localized ACSL5 is a key regulator of 
mitochondrial energy generation and apoptosis (Gassler et al., 2007; Klaus et al., 
2013). 
 
Role of Acyl CoA Synthases in Fatty Acid Uptake 
Cellular uptake of fatty acids derived from diet or synthesized by different 
tissues occurs either by passive diffusion or by facilitated transport. Because they 
are hydrophobic, it has long been thought that FAs move across the lipid bilayer 
and into a cell by either concentration-based flipping or passive diffusion.  
However, FA uptake studies deploying 1) saturation kinetics, 2) protein-mediated 
plasma membrane transport inhibition, 3) inhibition using nucleophilic fatty acid 
derivatives, and 4) competitive inhibition sensitivities (Glatz et al., 2010) indicate 
that protein-mediated uptake is important at physiological concentrations of fatty 
acids, and evidence for passive diffusion only emerges when fatty acids 
concentrations are quite high and presumably nonphysiological (Abumrad et al., 
1998, 1999). These studies have additionally identified several categories of fatty 
acid transporters. The integral and peripheral plasma membrane proteins that 
transport fatty acids into cells are known as “fatty acid transporter.” Included 
among these are fatty acid binding proteins (FABPs), fatty acid transport protein 
(FATPs), and  fatty acid translocases (Glatz et al., 2010). Of these transporters, 
the FATP family predominates and is the focus of the discussion that follows.  
 The FATP family was discovered in 1994 when Schaffer and Lodish 
screened for adipocyte proteins that increase cellular uptake of fluorescent FA 
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analogs (Schaffer and Lodish, 1994). Two positives that emerged from that 
screen were cloned: ACSL1 and FATP1.  In early studies of FATPs, it was found 
that these proteins shared several domains of sequence homology as well as 
their domain organization with well-characterized members of the acyl-CoA 
synthetase family.  This discovery led to the recognition that FATPs are dual 
functioning—albeit bona fide members of the adenylate forming acyl-CoA 
synthetase superfamily, and specifically the very-long-chain acyl-CoA synthetase 
subgroup (Stahl, 2004).  
 Once transported inside the cell, FA retention likely depends on vectorial 
esterification, wherein exogenous FAs are esterified to acyl-CoAs upon uptake 
and channeled subsequently into downstream pathways (for signal transduction, 
energy production, and/or membrane biogenesis).  Upon esterification, the once 
hydrophobic FAs are now negatively charged and thus unable to traverse the 
cell’s hydrophobic lipid bilayer by flipping or by  transporters, which are 
directional in their transport (Glatz et al., 2010).  
 In addition to cellular retention, there is also increasing evidence to 
suggest that the ACS activity of ACSL and ACSVL/FATP family members is 
necessary and/or sufficient to transport FAs into the cell.  Several studies show 
that ACS activity alone is sufficient for FA transport, and expression of fatty acyl-
CoA synthetases that are unrelated to the FATP-associated VLACS can enhance 
fatty acid uptake in Escherichia coli (Mangroo et al., 1995) and yeast (Tong et al., 
2006). In other scenarios, ACS activity is necessary in conjunction with 
transporter activity to facilitate FA transport. In 3T3-L1 adipocytes, ACS1 is an 
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integral membrane protein which colocalizes and interacts with FATP1 (Hall et 
al., 2003). Overexpression of either of these ACS1 or FATP1 increases fatty acid 
uptake, while their concomitant overexpression has a synergistic effect on fatty 
acid uptake (Gargiulo et al., 1999). When FATP1 contains a mutation that 
abolishes ACS activity, its overexpression severely suppresses FA uptake. 
Similarly, overexpressing normal FATP4 enhances FA uptake in COS cells, but 
overexpressing a FATP4 mutant that lacks ACS activity abolishes these effects 
(Mashek et al., 2007) .  Finally, overexpressing certain isoforms of either ACSL 
or FATP increases FA uptake despite the fact that ACSL1, ACSL4, ACSL5, and 
FATP4 are located only on intracellular organelles in the cells examined (Heimli 
et al., 2003; Marszalek et al., 2004; Mashek et al., 2006; Milger et al., 2006). 
These data suggest that FA uptake depends on inherent ACS activity of the cell 
and not on direct transport at the plasma membrane.  
 
Role of Acyl CoA Synthases in Fatty Acid Channeling 
 Once inside the cell, it appears that ACSs channel FAs into specific 
downstream pathways. The existence of 13 ACSL, FATP, and ACSBG isoforms 
that all activate long-chain FAs has led to the suggestion that each has an 
independent role in channeling FA within cells and there are several lines of 
evidence supporting this supposition. 
 In cultured mammalian cells, gain-of-function and loss-of-function studies 
strongly implicate the different ACSLs in channeling FAs into specific metabolic 
pathways, consistent with differences in their subcellular residencies and 
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substrate preferences. As examples, ACSL1 overexpression in either NIH-3T3 
fibroblasts or PC12 neurons increases oleic acid incorporation into 
Triacylglycerol (TAG) (Marszalek et al., 2004; Souza et al., 2002). In transgenic 
mice with heart-specific expression of ACSL1, TAG increases approximately 12-
fold in the heart and choline glycerophospholipid increases 50% (Chiu et al., 
2001).  In contrast, overexpressing ACSL1 in rat primary hepatocytes increases 
oleate incorporation into phospholipid and diacylglycerol, while decreasing 
incorporation into cholesterol esters and having no effect on TAG (Li et al., 
2006). In a study of ACSL3 knockdown in rat primary hepatocytes, decreased 
incorporation of labeled acetate into TAG and phospholipids was observed.   
 Altering the expression of FATPs similarly affects FA channeling. For 
example, FATP1 overexpression in HEK293 cells alters partitioning of both oleic 
acid (exogenously added) and FAs (synthesized de novo from acetate into 
cellular lipids) and increases cellular TAG content while decreasing cholesterol 
and sphingomyelin content (Hatch et al., 2002). In skeletal muscle, adenovirus-
mediated overexpression of FATP1 increases the partitioning of oleate or 
palmitate into TAG and decreases β-oxidation; overexpression in mouse heart 
increases FA uptake and TAG content and causes a lipotoxic cardiomyopathy 
(Chiu et al., 2001). Conversely, in muscle from FATP1 null mice fed a high fat 
diet, the content of TAG, DAG, and acyl-CoA is lower than in wild-type controls. 
Knockdown of FATP1 in 3T3-L1 adipocytes reduces FA uptake with no changes 
in lipolysis, but knockdown of FATP4 instead, increases basal lipolysis (Mashek 
et al., 2007). Thus, the specific effects of individual ACSs support the notion that 
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different ACSLs or FATPs channel FAs to distinct metabolic fates and the role of 
each isoform varies based on the tissue type.  
 It is possible that the differential effects of different ACS isoforms in 
different tissues result from tissue specific protein interactions. These interactions 
may determine the fates of acyl-CoAs synthesized by ACSs and thus channel 
them according to the metabolic demands of a given cell type. There is, however, 
only limited evidence to support the role of protein-protein interactions in  
channeling of Acyl CoAs. Immunoprecipitation of endogenous FATP1 from 3T3-
L1 adipocytes followed by mass spectrometry identified mitochondrial 2-
oxoglutarate dehydrogenase (OGDH), a key enzyme in the tricarboxylic acid 
cycle. Additionally, FATP1 enhances OGDH activity in proteoliposomes, whereas 
FATP1 knockdown in 3T3-L1 adipocytes showed decreased OGDH and TCA 
cycle activity (Wiczer and Bernlohr, 2009). These data suggest that channeling of 
Acyl CoAs occurs via interactions of metabolic enzymes with ACSs, and these 
interactions heavily influence metabolic reactions by controlling substrate 
availability.  However, it will be interesting to see if other FA channeling roles of 
ACSs require direct protein-protein interactions.  
 
Long-chain Acyl-coenzyme A Synthetase’s  
Role in Disease 
 Increases or decreases in ACSL isoforms under pathological conditions 
highlight the importance of optimal ACS function within an organism. Several 
ACS proteins have been implicated in a number of diseases; however, the 
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specific roles of these enzymes in disease conditions are completely understood 
only in a few cases.  
 Ichthyosis Prematurity Syndrome (IPS) is an autosomal recessive disorder 
characterized by premature birth, respiratory complications and dry, thickened, 
and scaly skin (Ichthyosis). The disease is caused by mutations in the gene 
encoding the FATP4 enzyme and a specific reduction in the incorporation of 
VLCFA into cellular lipids (Klar et al., 2009). The mutations identified are either 
nonsense mutations or missense mutations within the ATP binding pocket of 
FATP4. Studies of human IPS patients, as well as Fatp4 null mice, suggest that 
FATP4 plays a role in early epidermal development and that other ACS enzymes 
cannot compensate for a deficit of this enzyme. 
 Expression of the very long chain fatty acyl-CoA synthetase, ACSVL3, 
was found to be markedly elevated in clinical malignant gliomas in comparisons 
to normal glia (Pei et al., 2013). ACSVL3 levels correlated with the malignant 
behavior of human glioma cell lines with glioma cells propagating as xenografts. 
Direct ACSVL3 knockdown using RNA interference also inhibited glioma cell 
growth by 70% to 90%, while ACSVL3-depleted cells were less tumorigenic than 
control cells (Pei et al., 2009). It is now known that ACSVL3 maintains oncogenic 
properties of malignant glioma cells via up-regulation of Akt function (Pei et al., 
2009). 
 Several mutations in the ACSL4 gene are known to be causative of X-
linked mental retardation, a common cause for mental disability in young males. 
Deletions and missense mutations of the FACL4 gene are associated with 
16 
 
nonspecific mental retardation and with multisyndrome AMME complex disorder 
(Alport syndrome, Mental retardation, Midface hypoplasia, and Elliptocytosis). 
FACL4 is expressed in the human brain where it functions to activate 
polyunsaturated fatty acids (PUFA), like arachidonic acid (AA), eicosapentaenoic 
acid (EPA), and docosahexaenoic acid (DHA). In the mammalian brain, PUFAs 
function both as essential components of cellular membranes and as signaling 
molecules (Kantojärvi et al., 2011; Meloni et al., 2009; Yonath et al., 2011). It was 
proposed that defects in fatty acid metabolism due to the loss of FACL4 function 
can affect brain development. Cao et al. have shown that exposure to exogenous 
polyunsaturated fatty acids causes Caspase 3 dependent apoptosis in cell lines, 
and that this effect is abolished by overexpression of FACL4 (Cao et al., 2000). 
These data suggest that mutations in FACL4 cause nervous system damage via 
a direct cytotoxic effect of accumulated fatty acids. However, this hypothesis 
remains to be confirmed by in vivo studies.  
 Adenocarcinomas with an invasive phenotype and enhanced proliferation 
of enterocytes show decreased levels of ACSL5; however, it is unclear if ACSL5 
is causative of the disease (Gassler et al., 2003). ACSL5 is expressed in an 
ascending gradient along the crypt-villus axis of human small intestine with the 
highest expression level in enterocytes at the villus tip. It is thought that ACSL5 
sensitizes enterocytes to TRAIL (TNF-Related Apoptosis-Inducing Ligand)  
derived apoptosis susceptibility by down-regulation of the antiapoptotic FLIP and 
up-regulation of TRAIL-R1 receptors on the cell surface. TRAIL shows a 
corresponding gradient expression pattern. In sporadic intestinal 
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adenocarcinomas, the ACSL5 gradient is lost along with its reduced expression. 
Thus, a functional correlation between the appearance of an adenocarcinoma 
phenotype in the absence of ACSL5-derived apoptosis susceptibility of 
enterocytes has been considered (Klaus et al., 2014).  
 Elongases are downstream of ACSs in the fatty acid biogenic pathway. 
They produce FAs with longer acyl chains by using CoA esterified products from 
ACSs. Elongase of very long chain fatty acids-4 (ELOVL4) is the only 
mammalian enzyme known to synthesize C28-C36 fatty acids (McMahon and 
Kedzierski, 2010). In humans, ELOVL4 mutations cause Stargardt Disease-3 
(STGD3), a juvenile form of dominant macular degeneration (McMahon et al., 
2007). Heterozygous Stgd3 mice that carry a pathogenic mutation in the mouse 
Elovl4 gene demonstrate reduced levels of retinal C28-C36 acyl 
phosphatidylcholines (PC) and epidermal C28-C36 acylceramides (Barabas et 
al., 2013). Homozygous Stgd3 mice die shortly after birth with signs of disrupted 
skin barrier function. Targeted Elovl4 expression, driven by an epidermal-specific 
involucrin promoter in homozygous Stgd3 mice, restores both epidermal Elovl4 
expression and synthesis of the two missing epidermal lipid groups (McMahon et 
al., 2011). Transgene expression also restores skin barrier function and rescues 
the neonatal lethality of homozygous Stgd3 mice. These studies establish the 
critical requirement for epidermal C28-C36 fatty acid synthesis for animal 
viability.  
 Mutations in the peroxisomal ABCD1 transporter are responsible for X-
linked Adrenoleukodystrophy (X-ALD) in humans (Fuchs et al., 1994; Mosser et 
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al., 1994). The ABCD1 transporter is a cassette ATP binding protein that as a 
dimmer transports fatty acids activated by ACSs into the peroxisomes. X-ALD 
affects 1 in 17,000 births and is equally distributed among ethnic populations. 
Mutations in the ABCD1 gene can either lead to a severe neurodegenerative 
phenotype affecting the central nervous system or to a milder form of the 
disease, affecting only the peripheral nervous system (Adrenomyeloneuropathy 
[AMN]. The cerebral form of X-ALD manifests itself in otherwise normal children 
at about 3–5 years of age. Symptoms include anxiety, temperamental issues, 
difficulty in reading, and sensory loss (Berger et al., 2014). Sadly, these 
symptoms quickly progress to paralysis and death. The genetic modifiers that 
determine the severity of the phenotype have not yet been identified. Reduced   
activity of the peroxisomal ACSL proteins ACSBG 1 and 2 and elevated VLCFA 
levels in fibroblasts of X-ALD patients have been found, suggesting that ACSs 
could function as a genetic modifier of the clinical severity of X-ALD (Jia et al., 
2004; Moriya-Sato et al., 2000).  However, murine models using either the 
ABCD1 transporter gene and the ACSBG 1 and 2 genes in combination or alone 
have been unsuccessful in recapitulating the cerebral form of X-ALD and only 
exhibit mild abnormalities associated with Adrenomyeloneuropathy. Thus it is not 
yet clearly understood how a dysfunction in fatty acid transport leads to 
neurodegeneration.  
 Together these disease studies suggest that any imbalance in the activity 
of ACSs can lead to severe pathological conditions affecting a variety of systems 
in the body.  Thus, ACSs are critical metabolic regulators that play a significant 
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role in maintaining optimal physiology.   
 
ACSs in Development 
 Although a fair amount of research has focused on the diseases that result 
from ACS malfunction, the developmental processes dependent upon this family 
of  enzymes have remained largely unexplored.  Indeed, given the importance of 
ACSs in fatty acid metabolism and given that so many life-threatening diseases 
result from ACS malfunction, it would be surprising if ACSs played no critical 
roles in development.   
 Limited data suggestive of developmental roles for ACSs are two-pronged 
and include expression studies documenting differential ACSL transcriptional 
regulation during development, as well as diet studies documenting the effects of 
polyunsaturated fatty acids in mother's milk on development.  Expression studies 
have been useful in demonstrating that during 3T3-L1 adipocyte differentiation, 
Acsl1 mRNA abundance increases 160-fold while other transcripts encoding 
other ACSs remain unchanged (Marszalek et al., 2004), suggesting that ACSL1 
has an important role during adipocyte differentiation. In contrast, during the 
differentiation of PC12 neuronal cells, Acsl1 and Acsl3 mRNA levels remain 
unchanged, while that of Acsl4, 5, and 6 increases significantly (Marszalek et al., 
2004). Further, in mouse heart, Acsl1 mRNA increases 4-fold postnatally, while 
Acsl3 mRNA decreases and other ACSL isoforms do not change (de Jong et al., 
2007). Additionally, in Drosophila we have shown that six long chain ACS isoform 
are expressed early on in embryogenesis (Scuderi et al., unpublished data). Of 
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these, only two (the bubblegum [bgm] and double bubble [dbb] long chain acyl 
CoA synthase genes, which are homologous to the mammalian ACSBG) are 
expressed in a ventrally restricted pattern, and their mRNA levels seem to be 
differentially regulated during development.  Moreover, preliminary studies 
indicate that the expression of bgm and dbb is under the control of dorsoventral 
patterning genes (refer to Chapter 3).   
 A developmental role for ACSs has also been implicated in a very different 
line of research.  Clinical studies suggest that polyunsaturated fatty acids such as 
Omega 3 and Omega 6, both long chain fatty acids, are critical for proper 
development of the human embryo.  Absence or reduction of LCFAs in mother’s 
milk, as well as in the diet of children, has been associated with an increased 
predisposition to neurodevelopmental disorders including Dyslexia, Dyspraxia 
and the Autism Spectrum Disorders (Ward, 2000; Young and Conquer, 2005). 
Additionally, each of these neurodevelopmental  disorders is thought to result 
from disturbances in neuronal and/or glial membranes, which are rich in LCFAs 
and VLCFAs (Laycock et al., 2007). One reason why the developmental roles of 
long and very long chain fatty acids have not been explored systematically is the 
lack of a genetic model system that allows precise manipulations of small 
populations of fatty acids during activation of small, medium, or long chain fatty 
acids that will affect specific populations of fatty acids during development and 
thus provide a segue to their specific roles in development. To date, however, 
ACS knockout models in mice and flies have yielded only homozygous viable 
animals.   
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Drosophila ACSLs: A Genetic Model for	  
Human Developmental Disorders  
 Drosophila melanogaster provides a powerful genetic model, one that is 
widely used to study development and the pathogenesis of human degenerative 
disorders. The high degree of conservation of fundamental biological processes 
and neural function between humans and flies, coupled with the broad repertoire 
of fly genetic approaches, makes Drosophila a powerful model system for 
understanding the basics of molecular and cellular pathology of the vertebrate 
systems. In addition, fly genomes have little to no redundancy in genetic 
pathways, thus making forward genetics much more efficient and successful. 
This is especially true with respect to ACS genes, six of which exist in the fly 
compared to 26 in mammalian systems. Other advantages of the Drosophila 
model system include its low cost, compact and sequenced genome, and 
amenability to large scale genetic and pharmacological screens. While the lipid 
composition in the insects is different from mammals, the components of lipid 
metabolism pathways are conserved. As in humans, lipid homeostasis in 
Drosophila is tightly linked to systemic integrity and development, and loss-of-
function mutations affecting enzymes involved in Drosophila lipid metabolism 
manifest as developmental and degenerative changes in the fly. Significantly, fly 
models of several developmental disorders like Angelman syndrome, Rett 
syndrome, Neurofibromatosis Type 1, and Fragile X syndrome have recently 
been established (reviewed in Gatto and Broadie, 2011). These studies prove the 
existence of conserved pathways between flies and humans and indicate that 
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understanding fly development will go a long way in understanding human 
developmental processes. These investigations in Drosophila continue to provide 
the essential mechanistic understanding required to facilitate the conception of 
rational therapeutic treatments for developmental disorders. 
 There have been a few studies to explore the role of LCFAs/VLCFAs, 
lipids, and the enzymes responsible for their production in developmental 
processes using Drosophila as a model system. What follows is a brief overview 
of these studies.  
 There are three studies of Drosophila sperm that implicate very-long-chain 
fatty acids or their derivative phosphatidylinositol lipids in membrane biogenesis 
and/or its connection to contractile components during cell division.  First, 
mutations in the gene bond, which encodes a Drosophila member of the family of 
very long chain fatty acid elongase (Elovl), block or dramatically slow cleavage-
furrow ingression during early telophase in dividing spermatocytes (Szafer-
Glusman et al., 2008). In bond mutant cells at late stages of division, the 
contractile ring detaches from the cortex and constricts or collapses to one side 
of the cell, and the cleavage furrow regresses. 
 Perhaps the best known Drosophila story of lipids in development is the 
wunen story. Lipid phosphate phosphatases (LPPs) are integral membrane 
enzymes that regulate the levels of bioactive lipids such as Sphingosine 1 
Phosphate and lysophosphatidic acid. The two Drosophila LPPs, Wunen (Wun) 
and Wunen-2 (Wun2), have redundant roles in regulating the survival and 
migration of germ cells (Renault et al., 2010). wun and wun2 function in the 
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central nervous system and other somatic tissues to repel germ cells, likely via 
generation of a lipid signal. wun and wun2 also mediate germ cell–germ cell 
repulsion for germ cell dispersal to two embryonic gonads at the onset of germ 
cell migration. In addition, wun2 is required in the germ cells for their survival and 
to perceive the signal. Besides its well-established role in germ cell migration, 
wun also regulates the function of septate junctions: in wun mutants, the integrity 
of septate junction in the trachea and the blood–brain barrier is lost (Renault et 
al., 2010). 
 Our studies of the bubblegum (bgm) and double bubble (dbb) ACSs 
contribute to the short list of developmental lipid stories in Drosophila.  The 
Drosophila bgm gene, which encodes an ACSL, was identified in a P-element 
screen for genes that affect nervous system integrity. bgm mutants were found to 
exhibit subtle and incompletely penetrant defects in neuronal health. The 
similarities between bgm neurodegenerative phenotypes and human X-ALD are 
notable and perhaps not unexpected given that the fly and human genes 
responsible for this neurodegeneration are part of a single biochemical pathway 
(Min and Benzer 1999).   
 More recently we identified double bubble (dbb), a close homolog of bgm 
as a ventrally restricted transcript in an automated screen for transcriptionally 
regulated targets of early developmental signaling pathways (Simin, Scuderi et 
al., 2002). The sequence similarity of the bgm and dbb genes and their close 
proximity in the genome suggests that they are duplicated genes playing 
redundant or overlapping developmental roles. In order to analyze the functional 
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relationship between Bgm and Dbb, we generated dbb and bgm dbb mutant flies 
by homologous recombination.  We demonstrated that bgm dbb exhibit a more 
fully penetrant and more severe neurodegenerative phenotype than do either of 
the single mutants; thus the closely related genes function in redundant fashion 
in neuromaintenance (Anna Sivatchenko, unpublished data). Intriguingly, upon 
closer examination, we observed developmental defects in our bgm and  bgm 
dbb mutant lines, providing us with a previously unrecognized opportunity to 
study the developmental role of ACSLs in the fly.  
 
Summary 
 In studies presented in this dissertation, I show that the maternally derived 
bgm is required for Drosophila embryonic development and survival. bgm is 
required for cellularization, and failures in this very early developmental process 
appear to have later widespread manifestations as well (Chapter 2); I also report 
studies of regulation of bgm  and dbb gene expression (Chapter 3) and some 
behavioral studies relating to the neurodegenerative phenotype of bgm and dbb 
adult flies (Chapter 4). 
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  CHAPTER 2 
 
  LONG CHAIN ACYL CoA SYNTHASE: A NECESSITY 
TO MEMBRANES AND NEUROGENESIS  	  
  Introduction 
   Lipids, one of the four macromolecules of the cell, perform a diverse array 
  of extremely vital functions within every organism. Broadly, lipids directly or 
  indirectly participate in signaling pathways, act as building blocks within 
  membranes, are highly efficient sources of energy compared to carbohydrates, 
  and lastly directly or indirectly affect the availability of vitamins in the body, thus 
  affecting biochemical reactions and metabolism. 
   As components of biological membranes, the lipid composition of the 
  membrane defines the protein components of the membrane under consideration 
  and thus, lipids impart to each type of membrane in an organism unique protein 
  signatures and unique properties. At the plasma membrane, lipids form a 
  selective barrier that maintains a stable environment within the cell while also 
  maintaining a pathway for communication with the external environment. The 
  plasma membrane protein composition specifies the signaling pathways that are 
  active within a cell as well as the energy sources that enter the cell. Depending 
  on the type of lipids present, each membrane has a unique shape and also the 
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unique ability to change its shape in response to the demands of morphogenesis, 
migration, and the immune response, to name just a few biological processes 
(Bogdanov et al., 2014; Poveda et al., 2014; Schmidt and Robinson, 2014; 
Stachowiak et al., 2013). The lipid composition of a cell is very sensitive to the 
physiological state of the organism, and this sensitivity imparts a dynamic ability 
to the cell, in terms of energy sources used and the signaling pathways activated. 
This ability allows a cell and/or organism to adapt and survive in a changing 
environment. Thus, the role of lipids as building blocks for membranes is the 
most influential as it affects all aspects of a cell’s physiology (Abumrad et al., 
1999). 
 Lipids are amphiphilic: having both a hydrophilic end and a hydrophobic 
end. The hydrophobic chains of membrane lipids are derived from long or very 
long chain fatty acids which have 14 or more carbons in their acyl chains 
(Agostoni and Bruzzese, 1992). These help membrane lipids span the 
membrane either in pairs to form the lipid bilayer, or singly in the case of very 
long chain fatty acids, which can span the membrane in its entirety to facilitate 
curving. Importantly, the different fatty acids impart specific membrane bending 
or protein interaction properties to a membrane (Stachowiak et al., 2013). In 
contrast, short chain FAs are thought to function primarily as signaling molecules 
within the cell and medium chain FAs function primarily as energy sources; 
however, all these functions may not be exclusive to each class of FAs (Agostoni 
and Bruzzese, 1992).   
 Irrespective of their function, in order to participate in catabolic, anabolic, 
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or regulatory functions within the cell, FAs need to be esterified to Coenzyme A 
(CoA) (Watkins and Ellis, 2012). This esterification activates fatty acids and 
makes them energetically efficient as substrates in enzymatic reactions. The 
esterification reaction is catalyzed by the enzymes belonging to the Acyl CoA 
Synthetase/Synthase (ACS) family. ACSs catalyze a two-step reaction that is 
ATP dependent and leads to the formation of Acyl-CoA and two AMP equivalents 
(Watkins and Ellis, 2012). In mammals, 26 ACSs have been identified; of these, 
13 activate long and/or very long chain fatty acids (>14 carbons) (Mashek et al., 
2007). These ACSs include the members of the long-chain acyl-CoA synthetase 
(ACSL) family and members of the very long chain acyl-CoA synthetase 
(ACSVL) family, as well as members of the BGM family, which are mammalian 
ACSs homologous to the Drosophila long chain ACS Bgm (ACSBG). Some 
ACSVLs are dual functioning, serving as both fatty acid transporters (FATP) and 
acyl CoA synthases (Abumrad et al., 1998; Schaffer and Lodish, 1994). In 
addition to roles in esterification and transport, ACSs appear to facilitate the 
channeling of fatty acids to specific processes in the cell by associating with the 
specific enzymes/proteins. Moreover, the specific downstream pathways vary in 
a tissue-specific manner (reviewed in Mashek et al., 2007). Taken together these 
data indicate that each ACS isoform has a specific function and each isoform is 
different and important enough for it to be conserved through evolution.  
 Several ACSs and their downstream effectors in fatty acid biosynthesis 
have been implicated in a number of diseases. Ichthyosis Prematurity Syndrome 
(IPS) is an autosomal recessive disorder characterized by premature birth; 
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respiratory complications; and dry, thickened, and scaly skin (Ichthyosis). The 
disease is caused by mutations in the gene encoding the FATP4 enzyme and a 
specific reduction in the incorporation of VLCFA into cellular lipids (Klar et al., 
2009). Expression of the very long chain fatty acyl-CoA synthetase, ACSVL3, 
was found to be markedly elevated in clinical malignant gliomas in comparisons 
to normal glia (Pei et al., 2013). ACSVL3 levels correlated with the malignant 
behavior of human glioma cell lines with glioma cells propagating as xenografts. 
Direct ACSVL3 knockdown using RNA interference also inhibited glioma cell 
growth by 70% to 90% (Pei et al., 2009). Mutations in the ACSL4 gene are 
known to be causative of X-linked mental retardation, a common cause for 
mental disability in young males. Deletions and missense mutations of the 
FACL4 gene are associated with nonspecific mental retardation. Mutations in 
FACL4 cause nervous system damage via a direct cytotoxic effect of 
accumulated fatty acids. (Kantojärvi et al., 2011; Meloni et al., 2009; Yonath et 
al., 2011) Adenocarcinomas with an invasive phenotype and enhanced 
proliferation of enterocytes show decreased levels of ACSL5; however, it is 
unclear if ACSL5 is causative of the disease (Gassler et al., 2003). A functional 
correlation between the appearance of an adenocarcinoma phenotype in the 
absence of ACSL5-derived apoptosis susceptibility of enterocytes has been 
considered (Klaus et al., 2014).  
 Elongases are downstream of ACSs in the fatty acid biogenic pathway. 
They produce FAs with longer acyl chains by using CoA esterified products from 
ACSs. Elongase of very long chain fatty acids-4 (ELOVL4) is the only 
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mammalian enzyme known to synthesize C28-C36 fatty acids (McMahon and 
Kedzierski, 2010). In humans, ELOVL4 mutations cause Stargardt Disease-3 
(STGD3), a juvenile form of dominant macular degeneration (McMahon et al., 
2007). Targeted Elovl4 expression, driven by an epidermal-specific involucrin 
promoter in homozygous Stgd3 mice, restores both epidermal Elovl4 expression 
and rescues the phenotype.  
 Mutations in the ABCD1 transporter, which is downstream of ACSs in the 
peroxisomal fatty acid metabolic pathway,  are known to be causative of X-linked 
Adrenoleukodystrophy (X-ALD) in humans (Fuchs et al., 1994; Mosser et al., 
1994). The ABCD1 transporter is a cassette ATP binding protein that as a 
dimmer, transports fatty acids activated by ACSs into the peroxisomes. X-ALD 
affects 1 in 17,000 births and is equally distributed among ethnic populations. 
Mutations in the ABCD1 gene can either lead to a severe neurodegenerative 
phenotype affecting the central nervous system or to a milder form of the 
disease, affecting only the peripheral nervous system (Adrenomyeloneuropathy 
[AMN]). The cerebral form of X-ALD manifests itself in otherwise normal children 
at about 3–5 years of age. Symptoms include anxiety, temperamental issues, 
difficulty in reading, and sensory loss (Berger et al., 2014).  Sadly, these 
symptoms quickly progress to paralysis and death. The genetic modifiers that 
determine the severity of the phenotype have not yet been identified. Reduced   
activity of the peroxisomal ACSL proteins ACSBG 1 and 2 and elevated VLCFA 
levels in fibroblasts of X-ALD patients have been found, suggesting that ACSs 
could function as a genetic modifier of the clinical severity of X-ALD (Jia et al., 
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2004; Moriya-Sato et al., 2000). 
 ACSLs are thus quite clearly critical metabolic regulators and promising 
targets for the treatment of several diseases. Although a considerable amount of 
research has been done on diseases that result from ACS malfunction, 
surprisingly there are only a handful of studies that focus on the role of these 
enzymes in developmental processes. Given that so many diseases affecting 
different tissues result from ACS malfunction and knowing how important ACSs 
are in fatty acid metabolism, it seems likely that these enzymes must play critical 
roles in developmental processes as well. Moreover, the multiple roles of 
LCFAs/VLCFAs within membranes make them particularly interesting from a 
developmental perspective. Development entails extensive membrane 
remodeling, widespread cell migrations and movements, a hierarchy of signaling 
cascades, and most importantly energy to drive each of these processes.  Each 
of these functions is heavily influenced by LCFA/VLCFAs in the membranes and 
within the cellular cytoplasm, and it would be surprising if ACSLs played no 
critical roles in development.   
 Limited data suggestive of developmental roles for ACSs are two-pronged 
and include expression studies documenting differential ACSL transcriptional 
regulation during development as well as diet studies documenting the effects of 
polyunsaturated fatty acids in mother's milk on development. 
 Several clinical studies have suggested that polyunsaturated fatty acids 
such as Omega 3 and Omega 6 are critical for the development of the human 
embryo. Absence or reduction of LCFAs in mother’s milk or in the diet of children 
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has been associated with an increased predisposition to neurodevelopmental 
disorders including Dyslexia, Dyspraxia, and Autism Spectrum disorders (Ward, 
2000; Young and Conquer, 2005). Additionally, each of these neurodevelopmental  
disorders is thought to result from disturbances in neuronal and/or glial 
membranes that are rich in LCFAs and VLCFAs (Laycock et al., 2007). All these 
pieces of information make it impending to explore the role of LCFAS and ACSLs 
in development.  
 Expression studies have been useful in demonstrating that during 
mammalian and invertebrate development, many ACSL isoforms are differentially 
expressed, many of them during key developmental events (Marszalek et al., 
2004; Scuderi et al., unpublished data, refer to Chapter 3).  
 One reason why the developmental roles of long and very long chain fatty 
acids have not been explored systematically is the lack of a genetic model 
system that allows precise manipulations of small populations of fatty acids 
during development. It is likely that mutations in Acyl CoA synthases responsible 
for activation of small, medium, or long chain fatty acids will affect specific 
populations of fatty acids during development and thus provide a segue to their 
specific roles in development.  To date, however, ACS knockout models in mice 
and flies have yielded only homozygous viable animals (Heinzer et al., 2003). 
 Drosophila embryos, lacking the long chain acyl CoA synthases Bgm and 
Dbb, are the ideal genetic system to explore this subject. In addition to the 
excellent set of genetic tools available for study in Drosophila melanogaster, the 
fly embryo provides us with an excellent in vivo system that allows experimental 
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manipulation and microscopic observation. In this dissertation, I explore the 
developmental role of the highly conserved Drosophila proteins Bgm and Dbb 
during embryogenesis in Drosophila. I find that embryos derived from bgm 
homozygous females suffer an incompletely penetrant lethality very early in 
embryonic development. This lethality is due to a failure in cellularization. Loss of 
maternal bgm also leads to defects in neuromusculature and behavioral 
abnormalities in first instar larvae. At the molecular level, it appears that the Bgm 
ACS is required for vesicular targeting within the cell, and this failure in vesicular 
trafficking leads to a failure in cellularization.  
 
Materials and Methods 
Fly strains and genetic analysis 
 Wild type Canton S flies, mutant flies with the bgm1  null allele, the dbb 
null allele, and bgm dbb flies carrying both null alleles were used for all the 
experiments. The bgm1   as well as the dbb maternal zygotic stocks are 
homozygous semiviable or viable, respectively, and can be maintained as such.  
Flies lacking maternal  bgm were generated using standard genetic techniques 
where F1 progeny from a cross of  bgm1  females with Canton S males were 
collected. Zygotic bgm mutants were generated by crossing bgm1 / CyO females 
with bgm1 / CyO males and collecting F1 progeny with no GFP expression in 
them. The CyO balancer used carries a GFP transgene, thus marking any flies 
containing the balancer.  
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Immunocytochemistry 
 Embryos were collected at the appropriate stage after incubation at 25 C. 
Embryos were dechorionated and fixed using standard fixation methods except, 
when using Phalloidin. Ethanol was used instead of methanol for the 
divitellization step when Phalloidin staining was to follow. Standard 
immunostaining techniques staining techniques were used including the Rapid 
Staining Procedure (unpublished by Nipam Patel) in some cases. Primary mouse 
monoclonal antibodies were obtained from DSHB and used at these 
concentrations: Singleminded (1:300), Neurotactin (1:10), BP102 (1:200), Anti-
Futch/mAb22c10(1:100), Anti-Robo (1: 300). Anti-Rab 5 antibody generated in 
Rabbit was obtained from Abcam and used at 1:250 dilution. Secondary 
antibodies against mouse or rabbit primaries were tagged with Alexa 488 or 594 
in most cases. These were obtained from Jackson Laboratories and used at 
1:300 dilution. Phalloidin(Abcam) tagged with Alexa fluor 488 or 594 was used to 
stain filamentous actin.  
 
Microscopy 
 Live time lapse imaging of embryos was done by placing the embryos, 
after dechorionation, in halocarbon oil in a hydrated chamber. DIC or phase 
contrast or Fluorescence (when imaging transgenic flies) microscopy was used 
to capture images. Standard fluorescence microscopy and Confocal microscopy 
was done on the Olympus FV1000 microscope in the University of Utah 
microscopy core.   
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Larval assays 
 Peristalsis assay: 1st instar larvae which were about to hatch were 
observed under halocarbon oil using Phase contrast or Fluorescence 
microscopy(when transgenic GFP present). The time taken for one peristaltic 
wave to reach from the posterior end of the larva to the anterior end was 
measured as described by (Gjorgjieva et al., 2013). Nod assay: 2nd instar larvae 
were placed in a drop of water on a juice plate at 25 C. The number of head 
nods/ minute were measured. These measurements were repeated thrice per 
animal. Roll Over assay: 3rd instar larvae were placed dorsal side down on a 
juice plate at 25 C and the time taken to roll over so that the dorsal side is up, 
and move away was measured (Varnam et al., 1996). Each animal was tested 
using the assay three times and each measurement is an average of three these 
three measurements.  The number of animals for each experiment and assay 
was determined based on requirements for statistical significance. This averaged 
between 10-50 animals for each experiment.  
 
Statistical analysis 
 The error bars in all graphical representations in the present study 
represent standard error of mean (SEM). The significance values were calculated 
using standard statistical methods. Students t test,  paired t tests, one tailed or 
two tailed t tests were used depending on the hypothesis for a given experiment. 
ANOVA was used to calculate the significance values following the t tests.  
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Results 
Maternal bgm expression is required  
for embryogenesis 
 To determine whether defects in lipid metabolism lead to defects in 
Drosophila development, we assessed the consequences of loss-of-function for 
the homologous ACS genes bgm and dbb, alone and in combination.  Lethal 
stage analysis of bgm, dbb, and bgm dbb maternal-zygotic null animals revealed 
that whereas dbb homozygotes derived from dbb homozygous females are fully 
viable, bgm and bgm dbb maternal-zygotic nulls suffer an incompletely penetrant 
lethality that is confined to the embryonic stage of development. ~40% of both 
bgm and bgm dbb maternal-zygotic nulls suffer embryonic death, indicating that 
loss of bgm is sufficient to cause lethality in both bgm and bgm dbb animals, and 
bgm, but not dbb, plays an essential developmental role in Drosophila 
embryogenesis.   
 Embryonic transcription profiles for bgm and dbb are largely overlapping, 
although only bgm is deposited maternally (Figure 2.1B).  Given that only bgm is 
required for embryogenesis, we postulated that bgm-dependent lethality results 
from a strictly maternal effect.  Standard genetic methods were employed to 
generate embryos lacking either maternal or zygotic bgm only.  Consistent with 
our hypothesis, we found that only embryos deficient in maternal bgm (either as 
bgm1 homozyotes or bgm1 in Trans to deficiency) suffer an embryonic lethality 
(Figure 2.1C).   In both cases lethality occurred in 40% of embryos, confirming 
previous reports that that bgm1 allele is a null (Min and Benzer 1999; Sivatchenko 
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and Letsou, in prep).  Ubiquitous expression of UAS: bgm-FLAG using a 
Tubulin:Gal4 driver rescued embryonic lethality in embryos derived from bgm 
homozygous females (Figure 2.1D). 
 
The Bgm ACSL is required in cellularization for  
targeting of Rab 5 and Rab 11 vesicles  
to the growing furrow canals  
 To identify the developmental process that requires bgm, we visualized 
development in live embryos (Figure 2.1A).  Using time lapse microscopy, we 
documented failures in cellularization in 40% of embryos derived from bgm 
females. Embryos which successfully undergo cellularization complete 
embryogenesis and eventually hatch into larvae. However, embryos that fail to 
complete cellularization, also fail to progress in embryogenesis and abort 
development soon after. Therefore, failed cellularization accounts for all the 
embryonic lethality observed in lethal stage analyses (Figure 2.2A).  Moreover, 
although bgm-dependent lethality is incompletely penetrant, it results from a 
block at a single embryonic stage very early in development. This is only the 
second demonstration of a specific defect attributable to loss-of-function of a 
single very long chain fatty acidy acyl-coA synthase (Kniazeva et al., 2012). In 
Drosophila, cellularization occurs via multiple well-characterized steps (Lecuit, 
2004).  After 14 cycles of nuclear division, the 6000 zygotic nuclei move to the 
periphery of the embryo, immediately adjacent to the embryo plasma membrane. 
Columnar membrane structures called furrow canals ingress between aligned  












Figure 2.1:	  bgm is required maternally for embryogenesis.  
A. Lethal stage analysis of wild type and maternal zygotic loss of 
function mutants in bgm, dbb, and bgm dbb. 
B. Analysis of embryonic lethality in wild type embryos and embryos 
lacking either maternal zygotic, maternal, or zygotic bgm. Embryos 
derived from a crossing of bgm1/Df females with wild type males were 
also analyzed. 
C. Maternal and Zygotic expression patterns of bgm and dbb 
transcripts.  
D. Rescue of embryonic lethality in bgm1 embryos using a UAS:bgm 
FLAG    transgene  driven by a ubiquitous Tubulin::GAL4 driver. 
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nuclei. Membrane addition via vesicle fusion increases furrow canal length. After 
about 60 minutes, bilateral furrow canals fuse at the base of the nuclei; thereby 
each nucleus is enclosed within a contained cellular space.   In bgm-deficient 
embryos, all steps preceding the extension of furrow canals occur normally. 
Nuclei move to the periphery of the embryo and align, and furrow canal formation 
initiates. Once initiated, however, furrow canals fail to extend (Figure 2.2A).   
 Next we used the junction protein Armadillo/B-catenin to monitor furrow 
progression during cellularization. At the onset of cellularization, Armadillo is 
localized in an apicolateral position with respect to the nuclei.  In contrast, with 
completion of cellularization 3 hours after egg lay (AEL), Armadillo constitutes 
adherence junctions that are localized bilaterally along the furrow canals as they 
help the newly formed lateral membranes to be held tightly together.  Spaghetti 
squash (Sqh)/Nonmuscle Myosin-2 and filamentous Actin (F-Actin) produce the 
contractile force initially needed for extension of furrow canals and later for the 
fusion of the basal membranes. In congruence with their functional requirement, 
both these components are localized apicolaterally at the beginning of 
cellularization and basally with respect to the nuclei towards the completion of 
cellularization. 
 In bgm-deficient embryos, Armadillo and F-Actin fail to localize 
appropriately on completion of cellularization; instead, the proteins are distributed 
in a diffuse pattern apically, which is reminiscent of earlier stages of 
cellularization (Figure 2.2B, 2.2C). Mislocalization does not merely represent a 
delay in cellularization because these proteins fail to localize appropriately in  
	   46	  
 
Figure 2.2: The Bgm LACS is required for cellularization during 
embryogenesis. 
 
A. Analysis of furrow canal progression during cellularization in wild type and 
bgm1 embryos using time lapse phase contrast microscopy.  
B. Localization of Armadillo (Green) and blastoderm nuclei(Blue) in wild type 
embryos  (0 hours post fertilization (hpf) and 3.5 hpf) and bgm1 embryos (3.5 
hpf). 
C. Localization of filamentous actin and Spaghetti Squash (Nonmuscle 
myosin)(Red) along with blastoderm nuclei (Blue) in wild type and bgm1 
embryos 3.5 hpf. 
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bgm-deficient embryos even after an extended time period, and the embryos 
ultimately abort their development. These data confirm and extend results from 
our phase contrast studies indicating that bgm embryos suffer from an 
incomplete furrow extension that leads subsequently to a failure in cellularization.    
 The extension of furrow canals during cellularization requires enormous 
amounts of membrane addition, the majority of which is recycled from the 
embryonic plasma membrane using the endocytic machinery of the embryo. Rab 
5 and Rab 11 GTPases, important members of the endocytic pathway, have 
been shown to be necessary to the process of furrow extension during 
cellularization (Lecuit, 2004).  We have illustrated in the present study that 40% 
of bgm embryos fail to complete cellularization due to a failure in furrow 
extension. Given these data, we hypothesized that vesicle biogenesis and/or 
vesicle targeting is impaired in bgm-deficient embryos, and this leads to a failure 
in cellularization in 40% of the embryos. We tested this hypothesis by 
immunostaining of wild type and bgm embryos using antibodies directed against 
the Rab-5 protein to visualize vesicles. We observed a 2-fold increase in the 
number of membranous particles positive for Rab-5 in bgm-deficient embryos as 
compared to wild type.  Additionally, we observed enlarged Rab-5 positive 
compartments in the bgm-deficient embryos, but not in their wild type 
counterparts.  We suspect the later to be large vesicular bodies, also observed 
by Sheckman et al. (Wuestehube et al., 1996) in their yeast vesicle targeting 
mutants. Lastly, we observed that whereas the cellularization zone in wild-type 
embryos is divided into areas of dense (basally) and sparse (apically) vesicle 
	   48	  
distributions, such a partition of vesicles is absent in the cellularization zone in 
bgm embryos. We see the above defects in 65% of bgm embryos. These data 
imply that in the absence of the bgm gene product, proper targeting of Rab-5 
tagged vesicles does not occur, and this prevents the extension of furrow canals 
leading to a failure of cellularization. Similar experiments to visualize the 
localization of the Rab-11 GTPase are currently underway.  
 
Maternally deposited bgm is necessary for  
neuromuscular development  
in the embryo  
 Bgm is clearly essential for embryogenesis, yet only 40% of bgm maternal 
zygotic null animals suffer embryonic lethality, and the remaining 60% animals 
survive to adulthood. Data in the following sections demonstrate that although 
60% of bgm homozygous animals do not suffer from embryonic lethality, they do 
demonstrate developmental abnormalities that do not result in lethality. Thus, 
100% of bgm homozygous embryos suffer from developmental defects to 
different degrees of severity. Bgm expression throughout embryogenesis, 
combined with cellularization defects in a fraction of the embryos that survived, 
led us to speculate that loss of bgm might have additional developmental 
consequences (Figure 2.3). Additionally, during lethal stage analyses, we 
noticed that although all hatched larvae survived to adulthood, they were 
sluggish in their movements in comparisons to wild type. We used three motor 
assays to characterize and quantify these effects.  First, we quantified the rate of 
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Figure 2.3: Rab 5 vesicles are mistargeted in bgm1 mutants. 
Rab 5 marked vesicles (Red) are partitioned into a clear area of sparse 
(apical) and dense (basal) distribution with respect to the nuclei (Blue) in wild 
type cellularizing embryos. This differential distribution of vesicles is lost in 
bgm1 embryos, along with an increase in total vesicle number accompanied 
by an increase in large vesicular bodies. We observe all of these vesicular 
defects in all affected embryos and hence, they appear to be related to each 
other and to the primary causative event.  
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peristalsis at the time of hatching of wild type and bgm-deficient animals. In 
hatching wild type 1st instar larvae, one peristaltic wave takes less than 1 second 
to reach from the most posterior to the anterior most segments. However, in case 
of bgm larvae, the movement is asynchronous and variable and takes a 
significantly longer time (5–10 seconds) to propagate across the animal  (n = 
50/genotype). Second,  we measured head nods per minute in 2nd instar larvae. 
bgm larvae performed approximately 40 nods/minute compared to wild type 
larvae, which performed 100 nods/minute (n = 50/genotype, Figure 2.4B). Third, 
we measured the time taken by L3 larvae to roll over and move away after 
placing them with their dorsal side down. We find that while wild type L3 larvae 
take about 5–7 seconds to roll over,  bgm  larvae take 15–20 seconds to do the 
same (n = 100/genotype, Figure 2.4C). Thus, all three of the above assays at 
each larval stage demonstrate that loss of bgm during larval development leads 
to a 50% loss of motor function.  
 These data made us ask the obvious question: are these severe motor 
impairments caused by defects in the neuromusculature of the larvae or do they 
result from a defect elsewhere in the system? Based on microscopic analysis 
during the peristalsis assay, we find that the nervous system of larvae is severely 
compromised (data not shown). 
 We see that neuromuscular and behavioral defects in bgm maternal 
zygotic mutant larvae persist throughout larval development (Figure 2.4A). 
Maternally expressed bgm is required for early embryonic development, while 
zygotic expression of bgm seems to be required for maintenance of the adult 
	   51	  
nervous system (Sivachencko et al., unpublished). We wondered if the larval 
phenotypes in bgm maternal zygotic mutants are of maternal or zygotic origin. 
Also, do they arise due to a developmental abnormality, or are they early signs of 
neurodegeneration that we and Benzer et al. (Min and Benzer, 1999) have seen 
in the adult bgm flies? Interestingly, we find that based on preliminary 
experiments,  the behavioral and neuromuscular defects in bgm   1st instar larva 
arise from maternal loss of bgm (Figure 2.4D), whereas preliminary data 
suggests that the behavioral defects observed in 2nd and 3rd instar bgm larvae 
arise from loss of zygotic bgm (data not shown).  
 The early embryonic phenotype in bgm embryos, where we see defects in 
cellularization and finally a failure to complete embryogenesis, arises from a loss 
of maternal bgm expression (Figure 2.1C). Given that the larval motor defects in 
bgm mutants are also maternal in nature, it is highly likely that these behavioral 
defects arising from defects in the neuromusculature have an embryonic origin.  
We tested this hypothesis by using distinct markers to look at different stages of 
neuronal development in the embryo. We began our analysis at the earliest stage 
of neuronal development in the embryo and worked our way through later 
developmental stages. Neuroblasts first delaminate and appear in the ventral 
region of the embryo at Stage 9 and express the Singleminded (SIM) protein. 
Upon immunostaining Stage 9 embryos with an antibody against Singleminded, 
we found 1) the arrangement of neuroblasts in bgm embryos was highly 
disorganized and 2) the neuroblasts were reduced in number by 25–30% (180–
185 neuroblasts) compared to wild type embryos (225 neuroblasts). On further 
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Figure 2.4: Early larval movement defects in bgm1 embryos are maternal 
in origin. 
A. Measurement of time taken in seconds for a single propagation of the 
peristaltic wave in wild type and bgm1  1st instar larvae. 
B. Measurement of head nods/minute in wild type and bgm1 2nd instar larvae. 
C. Measurement of time taken in seconds to roll over in wild type and bgm1 
3rd instar larvae. 
D. Measurement of time taken in seconds for propagation of a peristaltic 
wave in wild type 1st instar larvae and bgm1 1st larvae lacking either maternal 
zygotic, maternal only, or zygotic bgm, respectively.   
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analysis, we find that defects in the nervous system—including absence of 
neuronal cell bodies and missing and/or mistargeted axons—continue to appear 
through later developmental stages. Immunostaining with an antibody against the 
protein Roundabout (Robo) at stage 13 and the antibody BP102 at stage 17, 
reveals severe defects in the axonal tracts of the central nervous system (Figure 
2.5A’). Specifically, in the stage 17 CNS of bgm embryos we observe breaks in 
the longitudinal fascicles as well as the commissures. In addition the 
commissures are frequently disorganized and cross over incorrectly.  Thus we do 
not see the ladder like pattern in the CNS of bgm embryos, which is typically 
observed in wild type embryos at this stage. Upon staining the stage 17 
peripheral nervous system using the mAb22c10/anti-Futch antibody, we find that 
in bgm embryos a large number of neuronal cell bodies are missing or 
mislocalized, in addition to defasciculation of the axon bundles arising from the 
four sets of cell bodies in each segment (Figure 2.5B). Both the CNS and PNS 
of bgm embryos have severe defects, and the phenotype is variably expressed. 
The number of segments affected as well as the severity of the axonal defects in 
each segment varies between bgm embryos. Upon quantification, a total of 
approximately 45% of bgm embryos (n = 300/genotype for each assay) show the 
above described phenotypes in the CNS and PNS. Significantly, we observe that 
the nervous system defects (Figure 2.5A) are always accompanied by defects in 
the musculature (Figure 2.5C). All neurons in the CNS and PNS arise as a result 
of mitotic cell divisions of the neuroblasts, and so any defects in neuroblast 
formation or division should result in missing or mislocalized neurons.  Absence 
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Figure 2.5: Movement defects in bgm1 1st instar larvae have an 
embryonic origin. 
A. Wild type and bgm1 embryos at stage 9, 13, and 17, respectively, stained 
using antibodies against Singleminded, Roundabout, and BP102.  
A’ Measurement of neuroblast number in stage 9 wild type and bgm1 
embryos stained with an antibody against Singleminded. 
B. Analysis of defects in the peripheral nervous system of wild type and bgm1 
stage 16 embryos using an anti-Futch antibody (mAb22c10). 
C. Analysis of neuromuscular defects in wild type and bgm1 stage 17 
embryos by staining filamentous actin in these tissues. Filamentous actin has 
been stained using phalloidin (Green). Ventral nerve cord seen in slightly 
ventralized views and the somatic musculature in lateral views.  
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or ectopic location of neurons may result in disorganization of the newly formed 
axonal architecture. We tested the possibility of mitotic phenotypes being 
correlated to the axonal phenotypes by colabeling embryos with the neuronal 
nuclear marker Singleminded and the F-Actin stain Phalloidin to mark the axons. 
DAPi was used as a general nuclear stain. Upon analysis, we found that reduced 
and disorganized neuronal nuclei in bgm embryos spatially coincide with a 
disorganized and/or damaged axonal architecture. It appears that in the absence 
of a given set of neurons, the nervous system of bgm embryos is unable to 
develop normally and results into a disorganized axonal architecture, presumably 
as the nervous system tries to compensate for the missing neurons. However, 
these data are correlative and not definitive. Live imaging or fate mapping of 
neuroblasts will be required to confirm the above described results. Neuroblasts 
in the Drosophila embryo are specified during the process of gastrulation, which 
follows immediately after completion of cellularization. Cellularization requires 
maternal expression of bgm, and the process of gastrulation requires many 
maternally expressed genes in addition to zygotic expression. Thus, it remained 
to be determined whether the defects in neuroblast formation and neuronal 
architecture arise from maternal and/or zygotic loss of bgm. In order to 
distinguish between the two possibilities,  we employed standard genetic 
methods to generate embryos lacking either maternal or zygotic bgm only. Loss 
of maternal bgm  accounts entirely for the neuromuscular defects (Figure2.6A) 
observed in the bgm  maternal zygotic mutants while zygotic loss of bgm has no 
significant effect (Figure 2.6B). In our close examination of embryos derived 
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from bgm females, we find that 40% embryos fail to complete cellularization and 
abort embryogenesis. However, a subset of the remaining 60% embryos show 
huge cells with incompletely formed cell membranes as seen using the 
membrane stain Neurotactin (Figure 2.6C). Additionally, during our time lapse 
imaging experiments to study the process of cellularization, we find that a small 
percentage of bgm mz embryos undergo only a partial failure in cellularization 
(data not shown). These defects in cellularization are localized to a small area of 
the embryo, and they do not cause the embryos to abort development. It is 
possible that these subtle defects in cellularization lead to the neuronal defects 
observed in bgm embryos.  
 
Discussion 
 In the present study we have demonstrated the requirement of maternally 
deposited bgm transcripts for furrow extension during Drosophila cellularization. 
Additionally, membrane vesicles, which are known to be absolutely critical to 
furrow extension, have been shown to be mislocalized in bgm1 mutant embryos. 
These data suggest that the failure in cellularization is due to defects in vesicle 
targeting. The extension of furrow canals during cellularization requires 
enormous amounts of membrane addition. This membrane is only partially 
synthesized de novo with the  majority of it recycled from the embryonic plasma 
membrane via endocytosis (Strickland and Burgess, 2004). Endocytosed 
vesicles harbor the GTPase Rab-5 and these Rab-5 vesicles are then targeted to 
and fuse with the recycling endosome (RE). Membrane components that will  
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Figure 2.6: Defects in the embryonic nervous system of bgm1 embryos 
have a maternal origin.  
A. Coimmunostaining of  neuroblasts (Singleminded, Green)  and axonal 
tracts (Phalloidin, Red) to determine origin of axonal defects.  
B. Analysis of neuronal defects using BP102 staining in wild type Stage 16 
embryos and bgm1 stage 16 embryos lacking either maternal zygotic, 
maternal, or zygotic bgm. 
C.Membrane staining in stage 9 wild type and bgm 1 embryos using anti- 
Neurotactin (Red) to demonstrate the presence of  huge cells  resulting from 
partial acellularization  in bgm1 embryos.  
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impart apicobasal polarity to the newly assembled cellular membranes 
postcellularization are also delivered to the RE via vesicular traffic from the Golgi. 
Here, in the RE, vesicles are repackaged with a defined set of cellular 
components intended for specific cellular compartments. The reconstituted 
vesicles contain GTPases in the vesicular membrane, and these GTPases 
function to 1) assign a specific identity to each set of vesicles and 2) target them 
to specific cellular compartments.  One particular class of vesicles harbors the 
Rab-11 GTPase on the vesicle surface, and fusion of these Rab 11 vesicles at 
the growing end drives the rapid extension of furrow canals during cellularization 
(Lecuit and Pelissier, 2003). The Rab-11 GTPase directs these vesicles to the 
furrow canals and thus allows furrow extension. However, it is not understood as 
to how Rab 5 tagged vesicles are specifically targeted to the RE and the Rab 11 
tagged vesicles from the RE are targeted to the growing furrow canals. Data 
presented in the current study demonstrate the requirement of the Bgm Long 
chain Acyl CoA synthase for targeting of Rab-5 vesicles during cellularization. 
Molecules acting as “Identifier signals” for subcellular vesicular targeting have 
been largely elusive to cell biologists, and our research is an important first step  
towards the discovery of such molecules. Based on the data presented in this 
study, we hypothesize that activated long chain fatty acids themselves or via 
interaction with specific proteins provide the identifier signal that directs Rab5 
vesicles to the recycling endosome and Rab 11 vesicles to the growing furrow 
canals. In the absence of the Bgm ACS, these activated LCFAs are missing and 
so is the identifier signal.  
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 Ours is only the second study to show the requirement of an Acyl CoA 
synthase in a specific developmental process. Kniazeva et al. have 
demonstrated the requirement of C. elegans Acsl-1 in cytokinetic processes 
during mitotic cell divisions in C. elegans embryogenesis. Additionally, a few 
studies in Drosophila have implicated enzymes required for lipid biogenesis and 
modification in cytokinesis of spermatocytes (Routt and Bankaitis, 2004). Thus 
there is emerging evidence for the role of Long chain fatty acids and enzymes 
required for their biogenesis in cytogenetic processes. We also provide evidence 
for the role of the Bgm ACSL in neurogenesis. The maternal requirement of bgm 
for the processes of neuroblast formation and axonogenesis suggests that these 
defects are related to a partial failure in cellularization. It is possible that failure in 
cellularization leads to a failure in proper cell fate specification, thus leading to 
defects in neurogenesis (Figure 2.7). However, experiments to obtain direct 
evidence to prove this hypothesis are underway. It is also possible that there is 
an independent requirement for LCFAs and the Bgm ACS for neurogenesis and 
axonogenesis. In either case, our findings are significant in light of the many 
clinical studies suggestive of a requirement of LCFAs and VLCFAs in  neuronal 
development. Several studies have implicated an imbalance in LCFAs and 
VLCFAs in neurodevelopmental disorders like Dyslexia, Dyspraxia, 
Schizoaffective disorder, and Autism Spectrum Disorders (ASD) (Das, 2013; 
Schuchardt et al., 2010).  All of these disorders have overlapping neurological 
symptoms accompanied by a dysfunctional immune response (Ward, 2000). 
Neuronal and glial membranes are very rich in LCFAs and VLCFAs and hence, 






Figure 2.7: Model for the role of Bgm ACS  and Long Chain Fatty Acids 
in cellularization and vesicle targeting. 
Endocytosed vesicles from the apical surface of the embryo are tagged with 
Rab5 GTPase(1). These vesicles are targeted towards the recycling 
endosome (2, RE) and use LCFAs or LCFA associated proteins as a signal to 
identify the RE compartment. New  membrane components from  the Golgi 
apparatus are also delivered to the RE(2’). Reconstituted vesicles from the 
RE are tagged with Rab11 GTPase and targeted towards the growing furrow  
canals during cellularization (3). LCFAs or LCFA associated proteins in the 
growing furrow  canals  are identified by Rab 11 GTPase, causing the Rab11 
vesicles to fuse with the furrow canals.  
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the nervous system is very sensitive to any changes in fatty acid metabolism 
(Laycock et al., 2007). In addition, a large number of signaling molecules 
required by the immune system are lipid based.  These findings in association 
with clinical studies,  are very suggestive of a suboptimal lipid metabolism in 
patients with neurodevelopmental disorders. Our findings are a significant first 
step towards a successful genetic model to understand the mechanistic role of 
LCFAs/VLCFAs and ACSLs in neuronal development. Further research in this 
direction will provide promising avenues for targeted treatment strategies, which 
are unavailable at the moment. 
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DROSOPHILA bgm AND dbb-DUPLICATED GENES DISPLAYING PARTIAL 
DIVERGENCE IN DEVELOPMENTAL EXPRESSION AND 
COREGULATED BY DORSAL PATHWAY GENES 
 
Introduction 
 Genetic analysis has allowed subdivision of the genetic loci involved in 
dorsoventral (DV) patterning into three conserved signaling pathways defined by 
the Epidermal Growth Factor Receptor (EGFR), Toll/Dorsal, and 
Decepentaplegic (Dpp), each of which transmits positional information through 
the localization of an extracellular morphogen. As development proceeds, 
sequential activities of these signaling cascades refine the positional identity of 
cells, giving rise to unique molecular and morphological characteristics for each 
domain along the dorsoventral axis.  
 The EGFR signaling cascade patterns the oocyte prior to fertilization. The 
TGF alpha-like ligand encoded by gurken provides the dorsalizing signal to the 
EGF receptor encoded by torpedo.  Thus, the most proximal follicle cells adopt a 
dorsal cell fate (Neuman-Silberberg and Schüpbach, 1993; Schejter and Shilo, 
1989). The signal generated by Gurken and Torpedo is transmitted subsequently 
through the Ras pathway; however, the events downstream of Ras are not 
 	  	  
completely understood (Brand and Perrimon, 1994). The dorsalizing signal 
represses transcription of the Dorsal/Toll signaling component Pipe (Sen et al., 
1998), thereby restricting activity of the Dorsal/Toll signaling pathway to the 
ventral-most regions of the embryo.  
 The Dorsal/Toll pathway is a maternal signaling cascade that interprets 
the DV signal initiated in oogenesis. Eleven dorsal group mutants and the 
negative regulator cactus were identified in genetic screens by their dramatic loss 
of DV positional identity (Anderson and Nüsslein-Volhard, 1984a; Morisato and 
Anderson, 1995). In the absence of any one dorsal-group gene, cells at all DV 
positions differentiate into dorsal epidermis, while ventral epidermis, 
neuroectoderm, and mesoderm fail to develop. Partial loss of function alleles 
leads to preferential loss of the ventral-most pattern elements (Anderson et al., 
1985). The DV pattern is based on a nuclear gradient of the maternal morphogen 
Dorsal, the Drosophila member of the NFκB family. dorsal mRNA and protein are 
uniformly distributed in the embryo, but the protein is selectively imported into the 
nucleus in a ventral to dorsal gradient (Roth et al., 1989; Steward, 1987). Proper 
generation of this gradient requires the upstream activities of the eleven dorsal-
group genes and cactus. Three somatic genes pipe, nudel, and windbeutel are 
transcribed in follicle cells and localize to the embryonic vitelline space where 
they initiate an activation cascade (Hong and Hashimoto, 1995; Manseau and 
Schüpbach, 1989; Sen et al., 1998). Ventrally restricted signaling by pipe, nudel, 
and windbeutel activates the Easter protease, which in turn leads to the localized 
proteolytic cleavage of the Spatzle ligand (Chasan et al., 1992; Schüpbach and 
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Roth, 1994; Smith and DeLotto, 1994). Cleaved and activated Spatzle activates 
the Toll receptor, allowing Toll to transduce the ventral signal intracellularly. Toll 
shares homology with the vertebrate interleukin-1 receptor (Gay and Keith, 
1991). Toll protein is uniformly distributed in the embryonic membrane; thus, 
restriction of the Spatzle ligand is essential for localized receptor activation 
(Hashimoto et al., 1991). A complex between two intracellular components of the 
pathway, Tube and Pelle, is presumably formed at sites of receptor activation 
(Towb et al., 1998). The serine threonine kinase Pelle interacts with the novel 
protein Tube via death domains present in both proteins, then signals to disrupt 
the inhibitory complex between Dorsal and its antagonist, the IKB homolog 
Cactus (Galindo et al., 1995; Letsou et al., 1991; Norris and Manley, 1992; Shen 
and Manley, 1998; Xiao et al., 1999). Similar to mammalian IKB, phosphorylation 
of Cactus marks it for ubiquitin-mediated degradation and releases the NFKB 
transcription factor, thus allowing it to enter ventral nuclei and regulate 
transcription (Beg et al., 1993).  
 Subdivision of the DV axis into distinct domains of transcriptional readout 
occurs in response to defined thresholds of Dorsal activity (Huang et al., 1997; 
Rusch and Levine, 1996). By acting as both transcriptional activator and 
repressor, Dorsal specifies domains distinguished at the molecular level by the 
expression of zygotic marker genes and at the morphological level by the cell 
fates that these domains predict. High levels of Dorsal in ventral-most cells 
pattern the mesoderm through the activation of transcription factors, Twist and 
Snail (Boulay et al., 1987; Thisse et al., 1987, 1988, 1991). Expression of Twist 
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and Snail is restricted to ventral cells by the inability of the low affinity binding 
sites in their promoters to be activated in more lateral regions (Pan et al., 1991). 
Intermediate levels of nuclear Dorsal activate neurogenic fate markers including 
rhomboid, short gastrulation, and single minded (Ip et al., 1992). Dorsal 
simultaneously restricts dorsal fates by repression of  decapentaplegic (dpp), 
zerkneult (zen), and tolloid (tld) in ventral and lateral domains (Ip et al., 1992; 
Shimell et al., 1991).  The inherent activator functions of Dorsal are transformed 
into repressor capabilities by interactions with additional cofactors (Dubnicoff et 
al., 1997; Jiang et al., 1992; Valentine et al., 1998). Together, Dorsal and its 
cofactors bind to neighboring sites in the promoter of the target gene and repress 
transcription. The absence of dorsal activity in dorsal-most cells permits 
expression of dpp, zen, and tld, allowing them to fix the limits of dorsal ectoderm 
and amnioserosa cell fates.  
 The Dpp ligand is a member of TGF-alpha superfamily of growth factors 
sharing the most extensive homology with vertebrate BMP 2A and BMP-4 
(Wozney et al., 1988). Transcriptional repression of dpp by Dorsal restricts dpp 
transcripts to the dorsal 40% of the blastoderm where it specifies dorsal cell fates 
(Irish and Gelbart, 1987; Wharton et al., 1993). 
 
Few Targets of Signaling Have Been Isolated Genetically 
 Taken together, the genetically defined pathways that specify dorsoventral 
patterning comprise signaling molecules and their attendant transcription factors, 
but very few of the targets of signaling have been identified to date. These target 
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genes are essential to our understanding of fate specification as they are the 
biological effectors of signaling. Identification and characterization of these 
effector targets will further our understanding of how they contribute to the 
determination of cell fates and in a broader context will provide insight into the 
developmental signals present in eukaryotes as a whole. Our limited 
understanding of the effectors of signaling may be due to our inability to identify 
genes with redundant functions, genes with both maternal and zygotic 
components, and genes with specialized developmental roles through classic 
genetic approaches. The forward genetic screens that successfully identified 
signaling components of patterning relied on mutations that would cause 
embryonic lethality and additionally resulted in some visible abnormality of the 
larval cuticle (Anderson and Nüsslein-Volhard, 1984b; Nüsslein-Volhard and 
Wieschaus, 1980; Wieschaus et al., 1984). Overall, only 25% (450) of the 1800 
lethal mutations generated caused embryonic death, and only 13% (580) of the 
embryonic lethal mutations caused visible alterations in the morphology of the 
larval cuticle (Wieschaus, 1996). In light of these numbers, as well as the relative 
paucity of effector molecules isolated in genetic screens, it appears likely that 
screening criteria were too stringent to identify most target genes.  
 At the level of transcriptional activation, the linear signaling pathway 
expands to regulate a diverse set of biological effectors. Effector molecules are 
expected to encode a wide range of biological functions. Some, such as 
structural proteins, enzymes, and cell adhesion molecules may directly generate 
the final differentiated state. Others, such as transcription factors and cofactors, 
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may serve as intermediate regulators in the differentiation process. These genes 
may share overlapping or interacting functions that make them difficult to isolate 
through classic genetic methods. In addition, because they are at the branch 
point of a linear signal, effector genes are expected to display only a subset of 
the characteristics that contribute to phenotypes displayed by the pathway as a 
whole; thus, phenotypes that arise from mutations in target genes will range from 
strong to nonexistent.   
 Finally, genes with redundant functions are also likely to be missed in 
genetic screens since both genes of the pair must be mutated simultaneously to 
disrupt shared functions. The Drosophila genome encodes 13,601 genes and 
based on sequence similarity alone nearly half of these are designated as 
duplicated genes (Adams et al., 2000; Rubin, 2000). Coupled with the genetic 
observation that only one third of loci mutate to a detectable phenotype, the high 
number of duplicated genes suggests that many nonmutable genes share 
redundant functions. However, at this point genome analysis cannot reveal 
functional requirements for duplicated genes. Additional approaches will be 
needed to distinguish duplicated genes that function redundantly from those that 
share sequence similarity but do not have overlapping functional requirements.  
 Few examples of functionally redundant genes have been reported in 
Drosophila. In these case studies, functional redundancy has been addressed in 
pairs of genes in which one partner was isolated genetically and the other was 
identified subsequently by sequence similarity. Examples include engrailed and 
invected (Coleman et al., 1987), knirps and knirp-like (González-Gaitán et al., 
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1994), and buttonhead and D-spl (Schöck et al., 1999). These related genes 
share similarities in sequence and expression profile, and in all cases the 
molecularly identified partner displays only a subset of the phenotypes presented 
by their genetically isolated counterparts. Duplicated genes with equivalent roles 
in development are expected to be more difficult to detect genetically.   
 
Effectors of DV Patterning Remain to Be Identified 
 Very few effectors or downstream targets of DV patterning have been 
identified to date. And taken together theses effector genes represent only a 
subset of the phenotypes that would result from complete loss of DV patterning, 
thus revealing many gaps in our knowledge of DV effectors. For example the 
transcription factor encoded by zen is a target of DPP signaling; however, zen 
mutants display a weak ventralized phenotype, and amnioserosa fates are lost 
while the dorsal ectoderm remains intact (Wakimoto et al., 1984). Thus, whereas 
Dpp patterns the dorsal domain in its entirety, transcriptional regulation through 
zen alone is not sufficient to provide all dorsal fates. Importantly, very few 
transcriptionally regulated targets of zen have been identified, and none of them 
display mutant phenotypes corresponding to their role in DV patterning (Hirose et 
al., 1994; Rusch and Levine, 1997; Tatei et al., 1995). Similarly, twist and snail 
are downstream targets of the Dorsal signaling pathway. However, both genes 
encoded are transcription factors, and very few cytological effectors downstream 
of this pair of genes have been identified. One example is folded gastrulation, 
which codes for a receptor that transduces the ventralizing signal into ventral 
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cells and is responsible for inducing the cytological changes that lead to ventral 
furrow formation during gastrulation (Costa et al., 1994). fog mutants display a 
failure to invaginate only in a subset of ventral furrow forming cells, and the 
effectors inducing changes in other cells still need to be identified (Dawes-Hoang 
et al., 2005).  
 
Conservation 
 One of the themes in developmental biology that has emerged over the 
past decade is that a small number of signaling pathways have been 
evolutionarily conserved, and these pathways are exploited repeatedly in 
numerous developmental and life history contexts within the same organism, as 
well as across species. As an example, Dorsal/Toll signaling mediates immune 
responses to microbial infection in flies, plants, and mammals (Anderson, 2000). 
Similarly studies in Xenopus have identified a BMP signaling pathways required 
for DV patterning analogous to Dpp signaling in Drosophila (Ferguson, 1996). 
 Signaling pathways have evolved various mechanisms to generate unique 
cellular responses at different developmental stages in different organisms. 
Modulation of the signal by the use of multiple ligands, receptors, differential 
endocytosis, receptor turnover, and crosstalk with other signaling pathways have 
been demonstrated to allow signaling pathways to elicit the correct biological 
response for each developmental event. As effectors of signaling, target genes 
are directly responsible for generating different biological responses. For 
example, the EGFR signaling pathway has been studied as a potential target for 
  
78	  
drug development, but because the core components are reused in so many 
distinct processes, emphasis has been placed on molecules involved more 
peripherally in signaling. Essentially, the emphasis is now on identifying effectors 
of signaling rather than the upstream drivers of signaling, with the hope for 
effective and localized responses to drug treatments. In this regard, identification 
and characterization of effectors that modulate specific subsets of signals 
represent an important next step. 
 
Expression-based Reverse Genetic Approach to  
Identify Effectors of DV Patterning 
 In order to identify effectors of DV patterning, we assayed expression 
profiles early in development. The rationale for the screen being that if an 
embryonic transcript is expressed early on in development and has a restricted 
pattern of expression, it must have a critical function at that time and place in 
development.  We used a high-throughput robotic screen for the identification of 
genes with spatially restricted RNA in situ expression patterns during the 0–4 
hours of embryonic development (Simin et al., 2002). Among the 778 sequence-
selected genes from a 0–4 hour embryonic cDNA library, some had established 
roles in pattern formation such as the pair-rule gene odd-skipped and the 
dorsoventrally restricted genes neuralized and delta. In addition, we discovered a 
number of novel genes with spatially restricted patterns of expression in the early 
embryo, like the dorsally restricted gene scylla, the charybde homologue. Our 
studies revealed scylla and charybde to be duplicated genes with essential (but 
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redundant) functions as effectors of the Dpp/Zen pathway in head involution 
(Scuderi et al., 2006). Our studies of scylla and charybde helped validate our 
approach to identification of biologically significant cell fate determinants in 
expression screens. A yet another previously unidentified dorsoventrally 
restricted gene that emerged from the screen was the U5F9 or CG4500 
transcript, which exhibited ventral expression in the blastoderm stage and in 
gastrulating Drosophila embryos (Simin et al., 2002).  
 
Material and Methods 
RNA in situ hybridization  
	   cDNA clones (LD28132 and GM14009), corresponding to dbb and bgm, 
respectfully, were obtained from BDGP. cDNA inserts were amplified from 
bacterial cultures diluted 1:50 in ddH2O by the polymerase chain reaction (PCR). 
Primers, SP6 and T7, specific for the pOT2 plasmid were used to amplify cDNA. 
Full-length antisense probes labeled with digoxigenin-UTP were generated using 
1ug of the amplified reaction product as template in an in vitro transcription 
reaction. RNA in situ hybridization to whole-mount Drosophila embryos and third 
instar larvae was performed as described (Tautz and Pfeifle, 1989). For 
detection, embryos and dissected larvae were incubated in alkaline phosphatase 
conjugated anti-DIG antibody (Boehringer Mannheim) diluted 1:2000, followed by 
incubation with chromogenic substrates 5-bromo-4-chloro-3-indolyl phosphate 
(BCIP) and nitroblue tetrazolium (NBT). The color reaction was terminated with a 
series of PBT washes with subsequent rinse in 100% methanol. Embryos and 
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larvae were cleared for 24 h in 80% glycerol, mounted on glass slides, and then 
scored using light microscopy. Embryos were classified by developmental stage: 
preblastoderm and blastoderm (stages 0–5), early gastrula (stages 6–8), and 
germ band extended (stages 9–11) (Campos-Ortega and Hartenstein 1997). 
Images were captured on an Zeiss Axioscope microscope using digital camera 
(AxioCam). 
 
Northern blot analysis 
 Nucleic acid manipulations were performed according to standard 
protocols (Sambrook et al., 1989). For northern blot analyses, total RNA was 
isolated from developmentally staged embryos, larvae, and adults. Approximately 
4 µg/lane were separated on denaturing 1% formaldehyde-agarose gels. 
Fractionated RNA was transferred to nylon membranes and immobilized by UV 
crosslinking. Hybridization with random-primed radiolabeled probes was 
performed by standard methods. 
 
Cryosectioning protocol for Drosophila embryos 
 Fix and perform in situ hybridization (RNA or Protein). Saturate embryos in 
sequential steps in sucrose + gelatin solution, with the final saturation being 7.5% 
sucrose+ 15% gelatin. Saturation/equilibration is when the embryos sink at the 
bottom of the tube of sucrose + gelatin solution. Start a set up with couple mug 
warmers and a few WET paper towels on top. Place one mug warmer under a 
dissecting scope. Place the plastic mould on the wet paper towel. Add about 25–
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50 ul of gelatin solution containing about 10–15 stained embryos. Have a couple 
forceps, the embryo containing vials of gelatin and extra gelatin solution heating 
on the other mug warmer. Line up the embryos in the vertical direction towards 
the front end of the mould (this is Side A). The easiest way to do this is take as 
little gelatin as possible. Drag embryos as you align them vertically towards the 
front of the mould, i.e., towards side A. Drag the next set of embryos towards 
Side A but behind the front row of embryos. This will prevent embryos from being 
disturbed.        
 Once you have a decent number of embryos aligned vertically, remove the 
mould from the mug warmer and set it down to cool. Once gelatin has solidified, 
gradually add small amounts of warm gelatin solution on top and fill up the mould 
to the top. Do not fill up with hot gelatin all at once, or the gelatin at the bottom 
will melt and all the alignment will be lost. Once fairly solid, place the mould 
overnight at -20 C. When ready to section, set the cryosection at -30 C at least 2 
hours in advance. Have the cryosection blade and chucks inside the 
cryochamber. Have liquid N2, OCT, and compressed CO2 at hand. The following 
should be done inside the Cryo chamber as much as possible. Remove the 
gelatin block from the plastic mould carefully without breaking it. Cut the plastic 
mould with a blade if needed to remove the gelatin block neatly.  Hold the block 
with a forcep and wave it very close to the surface of Liquid N2 but not within it. 
Expose all sides of the block to Liquid N2 in this manner. Once fairly solid and 
frozen, dip the block briefly into the Liquid N2 solution. Place a drop of OCT on 
the chuck and quickly place the frozen gelatin block on the OCT. Apply more 
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OCT on the chuck surrounding the gelatin block to provide support. Make sure 
Side A is facing towards you and is not stuck to the chuck because that is the 
part containing embryos and needs to be sectioned. Spray with compressed CO2 
and allow solidifying again inside the Cryo chamber. 
 When solid, cut out extra parts of the gelatin block without disengaging it 
from the chuck. Make it a nice square to obtain neat ribbons. Adjust the section 
thickness to 10 uM.  Adjust the angle of the chuck so that it is perpendicular to 
the blade. Adjust the glass over the blade so that it is completely aligned with the 
blade and not in front or back. Clean blade and the glass with ethanol and Kim 
wipes. Go ahead and section! If everything goes well, you should get neat 
ribbons that can be picked up by just touching a room temperature slide on top of 
the ribbon lightly. Keep these slides in the refrigerator overnight and cover with 
an aqueous mounting medium and coverslip the next day. Allow to dry and they 
are ready for microscopy. 
 
Results 
Acyl CoA synthases in Drosophila melanogaster 
 Examination of the nucleotide sequence revealed U5F9 to encode a long 
chain fatty acyl CoA Synthase (ACSL), which had not yet been characterized at 
the functional level. The predicted mRNA size of 2069 bp corresponded well with 
the 2.4 kb transcript detected in northern blot analyses. Database searches 
allowed us to uncover five Drosophila homologs of U5F9 in Drosophila 
melanogaster, which are also predicted to encode Acyl CoA synthases based on 
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their sequence (work done by previous graduate students: Anne Schuderi and 
Anna Sivachenko). However, the most closely related homolog was the gene 
bubblegum (bgm), and its protein sequence is 43% identical and 62% similar to 
that of U5F9 at the amino acid level. Homology extended across the entire length 
of the protein sequence (data not shown). Additionally, although all homologs of 
U5F9 identified are ACSs, only bgm and U5F9 encode long chain Acyl CoA 
Synthases.  U5F9 was later named double bubble (dbb) based on its close 
homology with bgm. bgm and dbb map only 7.6 kb apart from one another on 
chromosome 2L in the Drosophila genome. Hence in silico analysis suggests that 
bgm and dbb are duplicated genes with a common ancestor (Figure 3.1A).  
 In order to determine if any of the other ACS genes share the ventrally 
restricted spatial expression pattern with dbb, we performed mRNA in situ 
hybridization using RNA probes against some of the ACS genes (Figure 3.1B). 
Most of the ACS genes are ubiquitously expressed at 2 hrs AEL, when the dbb 
and bgm mRNAs are ventrally restricted. Their shared pattern of expression 
suggests that dbb and bgm are regulated by a common mechanism(s), at least at 
this stage of development and that both these genes have a potential role in 
mesodermal patterning.  
 
bgm and  dbb  are duplicated genes with differential  
gene expression during development  
 To gain insight into the evolutionary dynamics of the bgm and dbb gene 





Figure 3.1:Predicted Acyl CoA Synthases in Drosophila Melanogaster  
A. Phylogenetic tree of Acyl-CoA synthases in D. melanogaster. 
B. bgm and  dbb transcripts show overlapping expression profiles at stage 5 in 
Drosophila embryos. Note ubiquitous expression at Stage 5 of the genes 




region, to which bgm and dbb are localized and the genomes of ancestral 
Drosophila species, as well as to other insect genomes (refer to Sivatchenko 
thesis). We found that all Drosophilidae possess both the bgm/dbb gene pair and 
that in all species the genes are located in close proximity to one another. 
Furthermore, we have seen remarkable conservation of the exon-intron structure 
of bgm and dbb orthologs across all the Drosophila species. The analysis of 
other insect genomes revealed that A.gambiae, A. aegypti, N. vitripennis, and T. 
castaneum have one bgm ortholog. The genomic structure of the bgm group 
gene in Anopheles was similar to Drosophila bgm. These observations suggest 
that the ancestral gene is most homologous to the D. Melanogaster bgm, that 
dbb is the newly acquired gene, and that the gene duplication event has probably 
occurred in Drosophilidae lineage. Because bgm and dbb have different exon-
intron structures that are well conserved in ancestral species, the duplication 
event must be very old. Indeed, we have identified close homologues of bgm and 
dbb as far back into the speciation tree as in D. Pseudoobscura, suggesting that 
the duplication took place earlier than 43 million years ago. The bgm and dbb 
exonic sequences have high sequence similarity; however, the dbb single 
intronic sequence appears to be newly acquired as it appears neither in the bgm 
genomic sequence nor in any other gene in Drosophila or other species. Thus 
the dbb gene most likely arose by retrotransposition and postduplication; the 
gene acquired a new intronic sequence.  
 As a first step in studying the gene regulatory relationship between bgm 
and dbb genes, we used developmental Northern blots to visualize temporal 
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distribution of transcripts at critical stages in development. Consistent with the 
lack of maternally derived dbb expression in situ, transcripts were expressed at 
very low levels in RNA samples from 0–2 hr embryos. The peak of expression 
occurred at 2–8 hours after egg lay (AEL), concurrent with the onset of zygotic 
transcription. In subsequent stages dbb was expressed at low levels and was 
ultimately undetectable in larval stages. A second smaller peak of expression 
was observed during pupal development. Low level expression was observed in 
adults. The temporal expression profile of bgm was distinct from that of its 
homolog dbb. Expression of bgm peaked between 0–2 hr AEL, suggesting 
maternal depositions of the bgm transcript.  The expression of bgm mRNA was 
reduced between 2–16 hrs of embryogenesis, indicating low zygotic expression 
during embryogenesis. The bgm mRNA expression peaked again during larval 
and adult stages with reduced expression in pupal stages. These data suggest 
an overlapping as well as complementary requirement of the bgm and dbb 
transcripts during development (Figure 3.2A).  
 In order to assess the spatial relationship between bgm and dbb, we 
examined mRNA expression in staged whole-mount embryos (Figure 3.2B). 
Indeed, our analysis of mRNA expression localization revealed that bgm mRNA 
is maternally deposited as well as zygotically expressed, confirming the results 
obtained from Northern blot analysis. When zygotic expression begins in the 
embryo, both bgm and dbb exhibit overlapping, ventrally restricted expression 
patterns. This is in contrast to the transcripts corresponding to the other acyl-CoA 




Figure 3.2: Overlapping yet divergent expression patterns of bgm and 
dbb during embryonic development. 
A. Northern blot analysis of dbb and bgm. Developmental northern blots 
were hybridized with a radiolabeled probe for dbb or bgm. 
B.  Spatial distribution of bgm and dbb transcripts during embryogenesis. 
Stages are shown according to Hartenstein and Ortega 1997. bgm 
transcripts are deposited maternally, whereas dbb is expressed 
zygotically. Stage 5 expression patterns of bgm and dbb are 
overlapping, however the expression patterns diverge into distinct 
mesoderm derivatives at later stages. 




embryos.  It is only in later embryonic stages that the bgm and dbb gene 
expression profiles diverge, the most striking differences being their relative 
expression levels in mesodermal derivatives. The overlapping as well as 
complementary spatiotemporal expression patterns, as well as the difference in 
transcript levels of bgm and dbb at different developmental stages, suggest that 
changes in their regulation have allowed the duplicated bgm and dbb genes to 
evolve divergent developmental roles. It is possible that this pair of genes is 
under the control of both shared and distinct regulatory mechanisms for 
transcription.  Possibly, the initial zygotic transcription of both genes is controlled 
by a common signaling pathway, with slightly overlapping and differential 
mechanisms of regulation coming into play as the embryo progresses through 
embryonic development.  
 
Molecular epistasis 
 To place dbb within the developmental context of the well-characterized 
Dorsal pathway that specifies ventral fates, expression of dbb was examined in 
embryos lacking DV fate cues. In embryos derived from dorsal-deficient females, 
dbb expression is absent.  Conversely, in ventralized embryos, the extent of dbb 
expansion is proportional to the ventralizing strength of the mutant. The dbb 
expression domain expands from the ventral-most region of the embryo into 
lateral regions in embryos derived from females homozygous for a hypomorphic 
allele of cactus (cact011).  In contrast dbb expression expands to lateral as well 
as dorsal regions in embryos derived from females harboring a dominant 
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ventralizing (constitutively active) allele of Toll.  Together, these data indicate the 
Dorsal transcription factor is necessary and sufficient for dbb transcription 
(Figure 3.3A).   
 We next tested whether dbb is transcriptionally regulated by patterning 
genes downstream of  Dorsal signaling. The expression of transcription factors 
Twist (Twi) and Snail (Sna) is directly regulated by Dorsal, and the genes 
encoding these proteins represent the first zygotic targets of signaling in the 
Dorsal pathway. We assessed bgm and dbb mRNA expression in twist, snail, 
and twist snail double mutants in hybridization studies in situ (Figure 3.3B). We 
find that in both twist and snail single mutants there is reduced dbb mRNA 
expression as compared to wild-type embryos, while in the twist snail double 
mutants there is a complete loss of dbb mRNA expression. Thus, dbb 
transcription is controlled by both Twist and Snail and transcriptional inputs from 
both Twist and Snail were required for wild type expression levels of dbb. 
Analogous bgm experiments are ongoing, but preliminary studies indicate a 
similar pattern of regulation. The transcriptional regulation of dbb (and 
presumably bgm) by Twist and Snail places the Bgm and Dbb ACSs in a key 
position enabling them to impact mesoderm patterning. To further define their 
mesodermal expression domains, we examined transcription in cryosections of 
embryos at different stages of embryogenesis, starting at stage 5 (2 hrs AEL) 
when zygotic expression begins and the ventral furrow forms through stage 9, 
when germ band elongation initiates.  We observed both bgm and dbb mRNAs in 
each of tthe 18 ventral-most cells that undergo apical constriction and  
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Figure 3.3: dbb gene expression is regulated by the Dorsal pathway 
genes.  
 A. RNA in situ hybridization of stage 5 mutant embryos. Ventrally localized                                                             
wild-type expression of dbb mRNA is lost in dorsal  mutants, and partially 
or fully expanded in cactus and Tl10b  mutants.  
 B. Graphical representation of the loss of dbb mRNA expression in twist, 
snail,   and twist snail  mutant embryos shows partial reduction in the twi 
and sna single mutants and a complete loss in twi sna  double mutants. 
     (Experiments contributed by Anne Schuderi) 	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invagination during ventral furrow formation. Whereas bgm transcripts are 
distributed throughout the cell, dbb mRNAs appear to be restricted to the apical 
portion of these cells.  Restricted subcellular expression of mRNAs is rare, but is 
usually associated with localized translation. Such a machinery is able to  provide 
an immediate supply, with respect to time, of the specific protein at a given 
subcellular location (Besse and Ephrussi, 2008). Hence, it is intriguing to 
speculate that Dbb ACS activity is required specifically at the site of apical 
constriction in the ventral furrow forming cells. We have not observed any 
embryonic lethality associated with zygotic loss of bgm or dbb, either alone or in 
combination (Chapter 2); however, it is possible that the phenotype is very subtle 
and has thus been undetected. Given the very specific expression pattern of dbb 
mRNA,  we are conducting precise and careful experiments to determine any 
role of dbb in development of the ventral furrow.  For this analysis,   we will 
examine ventral furrow formation in live and fixed bgm, dbb, and bgm dbb mutant 
embryos using time lapse microscopy and high resolution techniques like 
Scanning Electron Microscopy.  Our expectation is that defects, if they exist will 
be subtle enough to not result in lethality, but may result in delayed and/or 
improper ventral furrow formation (Figure 3.4).  
 
Discussion 
 The bgm/dbb gene pair represents the second pair of duplicated genes 
(after scylla and charybde) that we identified based on an asymmetric pattern of 
DV axis expression.  As was the case for scylla and charybde, both bgm and dbb  
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Figure 3.4: dbb  and bgm  mRNA localization  in the ventral  furrow  
forming cells.  
Cryosections of wild type embryos at different stages of gastrulation  stained 
for dbb and  bgm transcripts. dbb transcripts are expressed in the ventral 
furrow forming cells starting at stage 5, and the mRNA is localized to the 
apical region of the cells, as shown by arrows. bgm transcripts are also 
present in the ventral furrow forming cells, albeit in a diffused fashion, as 
shown by arrowheads. 	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are regulated by the Dorsal signaling pathway, although their expression is 
restricted ventrally (rather than dorsally), and thus one or both may have roles in 
effecting ventral cell specific fates. mRNA localization is a widespread 
posttranscriptional mechanism for targeting protein synthesis to specific cellular 
sites. It is involved in the generation of cell polarity, asymmetric segregation of 
cell fate determinants, and germ cell specification. Lecuyer et al. employed a 
high-resolution fluorescent in situ hybridization procedure to comprehensively 
evaluate mRNA localization dynamics during early Drosophila embryogenesis.  
 Of the 3370 genes analyzed, 71% of those expressed encode 
subcellularly localized mRNAs. Tight correlations between mRNA distribution and 
subsequent protein localization and function indicate major roles for mRNA 
localization in nucleating localized cellular machineries (Lécuyer et al., 2007). 
Apical restriction of dbb transcripts in the invaginating cells of the ventral furrow 
is particularly intriguing, and we are currently investigating whether this 
localization facilitates Dbb function in ventral furrow formation. Based on other 
examples of subcellular RNA localization (Cody et al., 2013; Gaspar, 2011; 
Jansen and Niessing, 2012), it is possible that dbb mRNA localization to 
the apical side of invaginating cells assists in rapid translation and localization of 
the Dbb ACS and thereby facilitates rapid lipid-dependent remodeling of 
membranes at the cells’ constricting surface. The invaginating ventral furrow 
consists of a 18 cell wide stripe along the ventral midline of the blastoderm (Foe, 
1989). In a brief 10 min, these cells constrict apically and invaginate as a unit, 
forming a tube within the ventral portion of the embryo. In twist and snail mutants, 
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the ventral furrow does not form, and consequently mutants fail to develop 
mesoderm derivatives. The ventral furrow defects in twist and snail mutants 
represent the earliest visible requirements for zygotic transcription (Ferguson and 
Anderson, 1991). In fact, the window for transcription and translation of twist and 
snail targets is only 30–40 min, making it likely that target genes will encode 
effectors directly and that these effectors will correspond to modulators rather 
than structural proteins themselves (Simpson, 1983). Accordingly, both integrin 
subunit PS2a and Xanthine Dehydrogenase (rosy) are transcribed in cells that 
become the furrow (Leptin et al., 1989). An enzyme that catalyzes the activation 
of membrane components, such as dbb, also fits this prediction and fits the 
profile of an effector of DV patterning. 
Despite 60% sequence similarity (40% identical) of dbb and bgm, 
differences in their spatiotemporal expression profiles suggest that their functions 
have diverged. In this regard, results from northern blot studies are indicative of 
complementary roles in development.  Peaks of dbb expression correspond to the 
troughs of bgm expression.  Moreover, our observation that dbb transcripts 
accumulate apically at the site of constriction in invaginating cells of the ventral 
furrow tempts us to speculate that the developmental regulation of dbb in 
the embryo is important for the rapid membrane remodeling that takes place 
during gastrulation and possibly again later in embryogenesis, while bgm 
functions predominate later in larval and adult stages of the animal's life history.  
Comparisons of ventral furrow formation in wild-type, dbb, and bgm mutant 
embryos, required as a first step in testing potential mechanisms of dbb and bgm  
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function in ventral furrow formation, are ongoing.      	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CHAPTER 4 
 
DROSOPHILA ACYL CoA SYNTHASE MUTANTS DISPLAY MOTOR 
 
 DISABILITIES DUE TO PROGRESSIVE NEURODEGENERATION 	   	  
Introduction 
 Defects in fatty acid synthesis or distribution can have widespread effects 
on an organism. One specific tissue that is particularly susceptible to these 
defects is the nervous system.  Potentially fatal human neurodegenerative 
diseases such as Tay Sachs, Zelweger Syndrome, and Adrenoleukodystrophy 
(ALD) exemplify this (Moser, 1997; Schmitt et al., 2014). 
 Adrenoleukodystrophy (ALD) is a rare but oftentimes fatal progressive 
neurodegenerative disease. The most common form of the disease is X-linked 
(X-ALD); it occurs equally in all ethnic groups with an estimated incidence of 
1:17,000. X-ALD is a clinically heterogeneous disorder, exhibiting incomplete 
penetrance and variable expressivity (Moser et al., 2005). The most severe form 
of X-ALD is cerebral ALD, which affects about 45% of all patients (Moser, 1997). 
Demyelination in the central nervous system (CNS) constitutes the major burden 
of cerebral ALD accompanied by a treatable adrenal dysfunction—Addison’s 
disease. The disorder is diagnosed as progressive neurological dysfunction in 
previously healthy boys most commonly between the ages of 4 and 8 years old. 
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Affected children often present with school failure, hyperactivity, visual and 
hearing loss, cognitive impairment, and finally progression to paralysis and 
death. A less severe form of the disease, Adrenomyeloneuropathy [AMN], occurs 
in ~35% of X-ALD patients. In AMN patients, demyelination is confined to the 
peripheral nervous system (PNS). The gene responsible for X-ALD encodes a 
peroxisomal ATP-binding transporter (ABCD1) (Mosser et al., 1993). The ABCD1 
protein localizes to the peroxisomal membrane, where it functions to transport 
very long chain fatty acids (VLCFAs) into peroxisomes for their degradation. 
Indeed all X-ALD patients, including asymptomatic carriers, show elevated levels 
of VLCFAs in plasma, brain, and adrenal glands4, but whether this accumulation 
is causal to the neurodegeneration seen in ALD patients is not clear (Igarashi et 
al., 1976; Moser, 1997). Attempts to resolve the mechanism of 
neurodegeneration as well as the clinical heterogeneity of ALD in animal models 
have met with very limited success. 
 Acyl-CoA synthetases (ACSs) function immediately upstream of ABCD 
transporters and have been thought to be involved in ALD disease pathology. 
bubblegum (bgm), a Drosophila long chain acyl-CoA synthetase (ACSL), was 
isolated in a genetic screen for neurodegenerative mutants (Min and Benzer, 
1999). bgm mutant males exhibit neurodegeneration and elevated levels of 
certain VLCFAs indicative of a link between the bgm phenotype in flies and ALD 
in humans (Min and Benzer, 1999). However, bgm mutant flies recapitulate only 
some aspects of ALD and thus are far from perfect as an ALD disease model. 
Most of the ABC transporter or ACSVL synthetase gene studies in fly or mouse 
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models have not contemplated the huge potential for redundancy within both 
gene families. We have shown that a far more profound phenotype, and thus a 
better ALD disease model, is found in animals harboring mutations both in Bgm 
and its close homolog, Double bubble (Dbb), encoded by the dbb gene 
(unpublished from Anna Sivachenko). The high degree of conservation of 
fundamental biological processes in humans and flies, coupled with a broad 
repertoire of fly genetic approaches, makes Drosophila a powerful model system 
for understanding the molecular and cellular pathology of the nervous system 
(Celotto and Palladino, 2005; Kretzschmar, 2005; Nichols, 2006).  
 To study the functional relationship between bgm and its homologue dbb in 
the maintenance of adult CNS integrity, Sivatchenko et al., (Sivachenko and 
Letsou, in prep) analyzed brain morphologies in 18-day old wild type, single and 
double mutant flies. Histological and statistical analyses, of bgm1, dbbKO (both 
phenotypic nulls) and bgm1 dbbKO brain sections revealed optic lobe and retinal 
degeneration. Degenerative changes were much stronger in the bgm1 mutant 
than in the dbbKO mutant; however, the double mutant had a significantly worse 
phenotype compared to the wt and both single mutant flies. Our analysis 
indicates that these abnormalities occur after retinal differentiation is complete, 
and this is reminiscent of the human ALD phenotype where neurodegeneration 
affects previously normal children.  
 One of the major focal points of our research is identification of potential 
routes for therapy. This can be addressed either by diet intervention or by 
identification of potential drug therapies to target the ACS biochemical pathway. 
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For this, we need to conduct large-scale diet and drug screens and thus require a 
phenotype that is more easily scored than brain morphology. Also importantly, 
having documented severe eye abnormalities in bgm dbb double mutants, we 
seek to determine if the neurodegeneration is global or whether it is restricted to 
the eye. In order to address these questions, I used three different behavioral 
assays that have been previously reported to be optimally representative of 
neuronal abilities in the fruit fly.  
 
Materials and Methods 
Negative geotaxis assay  
 Flies are singly placed in an empty fly vial and tapped to the bottom. The 
time taken by each fly to reach a marked position at the top of the vial is 
measured. The experiment is repeated thrice for each animal.  
 
CO2 recovery assay 
 Flies are exposed to a specific dose of CO2 while placed on the diffuser, 
and the time taken to recover, i.e., to move and climb the vial is measured. The 
experiment is done with single flies and is performed only once/day with each 
animal due to the increased recovery times upon repeated exposures.  
 
Results 
 In both, a negative geotaxis (climbing ability) and CO2 recovery assays, we 
observed significantly reduced abilities in 15-day old bgm dbb and bgm flies 
	   106	  
compared to similarly aged wt flies (Figure 4.1). These differences in behavior 
between the wild type and mutant flies were only observed at a higher 
temperature of 25 C and not at 22 C. Thus these phenotypes are indicative of a 
temperature sensitive motor dysfunction. The Dbb ACSL does not seem to 
significantly contribute to this phenotype. Thus these data demonstrate that  
there is widespread neurodegeneration in the bgm and bgm dbb ACSL mutants 
which affects the motor behavior of these animals. Additionally, the behavioral 
defects in bgm dbb double mutant flies are comparable to those seen in bgm 
flies, suggestive of the fact that loss of bgm accounts for the behavioral defects in 
the double mutants and dbb has an accessory role. Hence, only bgm or bgm dbb 
flies will be accessed for the treatment of neurodegeneration in drug screens.  
 In order to further validate the behavioral phenotypes of our ACSL mutants 
in terms of neurodegeneration we assessed whether the progressive pattern of 
neurodegeneration observed in the eye and brain phenotypes, is also evident in 
the behavior of bgm dbb double mutant flies. As a first step we performed these 
studies only in wild type and bgm dbb mutant flies because the double mutants 
are comparable to bgm mutant flies in terms of the behavioral phenotypes and 
dbb mutants have no significant behavioral defects.  We used the Negative 
Geotaxis assay to determine if progressive neurodegeneration affects behavior. 
We find that wild type flies perform consistently well starting from day 0 to day 15 
in our behavioral assays. However, while bgm dbb mutants are comparable to 
wild type flies from day 0 to Day 7, they begin showing signs of motor dysfunction 
starting at day 7 or 8 approximately. We also see significantly more death in the  
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Figure 4.1:Behavioral defects in 15-day old  bgm  and bgm dbb  
adult flies at 25 C.   
A. Graphical representation of time taken(seconds) to climb a vial 25 C 
by wild type, bgm, dbb, and  bgm dbb 15-day old flies during the 
Negative Geotaxis assay.   
B. Graphical representation of time taken(minutes) to recover at 25 C 
by wild type, bgm, dbb, and  bgm dbb 15-day old flies during the CO2  
recover assay. 
C. Temperature sensitive negative geotaxis behavior of bgm dbb 
mutants.	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double mutant flies compared to wild type starting at day 7. The behavioral 
phenotype however, does not worsen from day 8 to day 15. It is known that the 
development of the adult Drosophila nervous system is complete at the time of 
eclosion.  Since the bgm dbb flies appear comparable to wild type for the first 6 
days posteclosion and show behavioral abnormalities starting at day 8, these 
phenotypes are suggestive of the onset of neurodegeneration at day 8 (Figure 
4.2). Significantly, the results suggest that neurodegeneration in the bgm dbb 
flies begins at day 8 at the latest, as opposed to the previously reported retinal 
neurodegeneration occurring at day 18.  
 
Discussion 
 In summary, we have shown that bgm and bgm dbb mutants exhibit 
widespread neurodegeneration, as shown earlier by Sivachenko et 
al.(Sivachenko and Letsou, in prep) in the retina and as evidenced by behavioral 
abnormalities discussed in the current study. The behavioral phenotypes are also 
temperature sensitive. This is suggestive of a role of the Bgm ACSL  or their fatty 
acid products in neuronal or glial membranes, and increased temperatures 
presumably make these membranes more susceptible to damage thus leading to 
behavioral abnormalities (Sepp and Auld, 2003). Lastly, neurodegeneration, as 
assessed from the behavioral phenotypes, appears to begin much earlier than 
the previously reported retinal degeneration. We begin to see behavioral 
abnormalities in bgm dbb flies at day 7/8 posteclosion, whereas retinal 
degeneration in our laboratory, as well as by Min and Benzer (Min and Benzer,  
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Figure 4.2: Neurodegeneration starts at Day 8 in bgm dbb mutants. 
Graphical representation of the performance of Day 1, Day 8, and Day 
15 wild type and bgm dbb flies in a Negative Geotaxis assay at 25 C. 
Mutant flies show signs of neurodegeneration starting at Day 8 post 
eclosion. 	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1999), has been reported only at day 18. It will be interesting to see if the 
neurodegeneration that presumably results in behavioral abnormalities at day 7/8 
also affects eye and brain tissues.  
 Lastly, we have shown that behavioral abnormalities indicative of 
widespread neurodegeneration do occur in the bgm and bgm dbb flies and these 
phenotypes can be used to assess effects of remedial treatments in drug screens  
and diet studies. When taking up large scale drug screens or diet studies, it will 
be helpful, however, to automate the process and access the effects of diet and 
drugs on a large number of flies under highly controlled conditions. Automation 
will help us reduce environmental and experimental variations, which can 
drastically affect behavior. Additionally, the phenotypes observed in our ACSL 
mutants are variably expressed and are reminiscent of human ALD patients. 
Automation will help us assess phenotypes and treatment effects in a large 
number of flies, thus providing high statistical power and will allow us to focus on 
the most promising treatment alternatives.  
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SUMMARY AND PERSPECTIVES 	  	   In Chapter 2 of the present study we have demonstrated the requirement of 
maternally deposited bgm transcripts for the processes of cellularization and 
neurogenesis. Specifically, bgm is required for the proper subcellular targeting of 
Rab 5 endocytic vesicles that are critical to furrow extension during Drosophila 
cellularization. The extension of furrow canals during cellularization requires 
enormous amounts of membrane addition, which in most part is supplied by 
endocytic vesicles (Strickland and Burgess, 2004). However, it is unclear as to 
how these vesicles are targeted to specific subcellular compartments that finally 
lead to membrane addition at the growing furrow canal. Data presented in the 
current study demonstrate the requirement of the Bgm Long chain Acyl CoA 
synthase for the proper targeting of Rab-5 vesicles during cellularization. This is 
significant, as the search for identifier signals for subcellular targeting has 
continued for long and our research is an important  first step towards the 
discovery of such molecules. Based on the data presented in this study, we 
hypothesize that activated long chain fatty acids themselves or via interaction 
with specific proteins provide the identifier signal that directs Rab5 vesicles to the 
recycling endosome and Rab 11 vesicles to the growing furrow canals. In the 
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absence of the Bgm ACS, these activated LCFAs are missing and so is the 
identifier signal.  
 Importantly, ours is only the second  study to show the requirement  of an 
Acyl CoA synthase in a specific developmental process. Kniazeva et al. have 
demonstrated the requirement of C.elegans Acsl-1 in cytokinetic processes 
during mitotic cell divisions in C.elegans embryogenesis. Additionally, a few 
studies in Drosophila have implicated enzymes required for lipid biogenesis and 
modification in cytokinesis of spermatocytes (Routt and Bankaitis, 2004). Thus 
there is emerging evidence for the role of Long chain fatty acids and enzymes 
required for their biogenesis in cytogenetic processes. This is intriguing, because 
thus far, in spite of lipids being important structural molecules within a cell, only 
proteins have been implicated in a majority of processes relating to cytokinesis. 
Thus, ours is one of the first few studies in an emerging field to study the role of 
lipids and long chain fatty acids in cytogenetic processes. These studies can 
have far reaching developmental implications because cell divisions in early 
embryogenesis define the embryonic and finally, the organismal body plan. 
Subtle defects or alterations in the properties of membranes may be overlooked 
during embryogenesis but may be manifested as developmental disorders at 
later stages, when cellular demands in terms of signaling and energy 
requirements are much more complex. Such a model of a developmental scar 
probably explains the neuronal abnormalities that we see in bgm  mutant embryos 
and may provide a model for genetic predisposition to neurodevelopmental 
disorders.  What follows is a discussion of the role long chain fatty acids in 
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neuronal development.  
 In Chapter 2, we also provide evidence for the role of the Bgm ACSL in 
neurogenesis. Loss of maternal bgm transcript leads to reduced number of 
neuroblasts as well as defects in  axonogenesis. In addition to bgm embryos, 
which suffer a complete failure in cellularization and thus suffer lethality, we also 
observe the presence of partially cellularized bgm embryos that do not suffer 
lethality. These data, along with a maternal requirement of bgm for neuroblast 
formation,  suggest that the neurogenesis defects in bgm  embryos may arise 
from a partial failure in cellularization. It is possible that partial failure in 
cellularization leads to a failure in proper cell fate specification, thus leading to 
defects in neurogenesis. However, experiments to obtain direct evidence proving 
this hypothesis are currently underway. It is also possible that there is an 
independent requirement for LCFAs and the Bgm ACS for neurogenesis and 
axonogenesis. In either case, our findings are significant in light of the many 
clinical studies suggestive of a requirement of LCFAs and VLCFAs in  neuronal 
development. Several studies have implicated an imbalance in LCFAs and 
VLCFAs in neurodevelopmental disorders like Dyslexia, Dyspraxia, 
Schizoaffective disorder, and Autism Spectrum Disorders(ASD) (Das, 2013; 
Schuchardt et al., 2010). Most of these disorders have overlapping neurological 
symptoms accompanied by a dysfunctional immune response (Ward, 2000). 
Neuronal and glial membranes are very rich in LCFAs and VLCFAs and hence, 
the nervous system is very sensitive to any changes in fatty acid metabolism 
(Laycock et al., 2007). In addition, a large number of signaling molecules 
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required by the immune system are lipid based (Mendelson et al., 2014). These 
findings, in association with clinical studies,  are very suggestive of a suboptimal 
lipid metabolism in patients with neurodevelopmental disorders. Our findings are 
a significant first step towards a successful genetic model to understand the 
mechanistic role of LCFAs/VLCFAs and ACSLs in neuronal development. 
Further research in this direction will provide promising avenues for targeted 
treatment strategies, which are unavailable at the moment.  
 In Chapter 3, our studies of the developmental expression patterns of the 
homologous bgm  and dbb  ACSL genes provide interesting perspectives 
regarding the duplication of these genes. In addition, the transcriptional 
regulation of this gene pair by the dorsoventral patterning genes of the Dorsal 
pathway makes them interesting candidates as effectors of Dorsoventral 
signaling. In addition, the specific localization of the dbb transcript at apical 
margins of invaginating ventral furrow cells may be indicative of its role in rapid 
membrane remodeling required, first for the apical constriction of invaginating 
ventral furrow cells and later for cell movements driving morphogenesis in the 
Drosophila embryo. The absence of a strong phenotype, associated with the 
apical localization of dbb mRNA, could be due to the presence of a yet 
unidentified ACSL, which functions redundantly along with Dbb. However, as 
potential effectors of dorsoventral patterning, it is not surprising that bgm and dbb 
mutants present with no phenotypic manifestations with regards to their ventrally 
restricted expression pattern in the prospective mesoderm. The absence of a 
phenotype could be due to an unidentified redundancy or the possibility of a very 
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subtle unidentified phenotype itself. Both of these possibilities are worth 
pursuing, and experiments in the lab are underway to further explore these 
venues of investigation.  
 In Chapter 4 we have presented preliminary evidence of behavioral defects 
in Drosophila mutants of Bgm and Dbb ACSs.  These data provide a segue 
towards easily scored phenotypes to be used for drug screens and nutritional 
intervention aimed at finding potential therapies for neurodegenerative diseases.  
 Overall, we present a comprehensive study of the developmental regulation 
and roles of long chain acyl CoA synthases in Drosophila. We have provided 
compelling evidence for the role of Bgm ACS as a key developmental regulator 
during Drosophila embryonic development. Given the high degree of 
conservation between the Drosophila and mammalian ACSs, including Bgm and 
Dbb, our studies will play a significant role in uncovering the role of ACSs and 
their associated long and very long chain fatty acids in human development and 
disease.  
 
 
 
 
 
 
 	  
